TrialID,BaselineMeasures,ZeroShot,OneShot,TwoShot,ThreeShot
NCT00385580,"Age Continuous, Age, Customized, Sex: Female, Male, Ethnicity (NIH/OMB), Race/Ethnicity, Customized, Eastern Cooperative Oncology Group (ECOG)Performance Status (PS), Height continuous, Weight continuous, FACT Advanced Prostate Symptom Index (FAPSI) -8 Score from baseline, Urinary N-telopeptide (uNTx)Value from Baseline, Bone-specific Alkaline Phosphatase (BAP) Value from baseline, ","Age, race, baseline PSA level, Gleason score, stage of prostate cancer, number of previous hormone therapies, duration of current androgen deprivation therapy, presence of bone metastases, presence of visceral metastases, performance status, testosterone levels, hemoglobin levels, alkaline phosphatase levels, lactate dehydrogenase levels, renal function, liver function","Age, Sex: Male, Race/Ethnicity, Prostate Cancer Stage at Study Screening, Gleason Score at Diagnosis, Baseline Prostate-Specific Antigen (PSA) Level, Testosterone Level, Eastern Cooperative Oncology (ECOG) performance status, Presence of Metastatic Disease, Prior Androgen Deprivation Therapy Status","Age, Continuous, Sex: Male, Race/Ethnicity, Customized, Baseline Prostate Specific Antigen (PSA) Level, Gleason Score at Diagnosis, Metastatic Sites, Baseline Testosterone Level, Prior Androgen Deprivation Therapy (ADT) Duration, Eastern Cooperative Oncology Group (ECOG) Performance Status","Age, Continuous, Sex: Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Baseline PSA Level, Gleason Score at Diagnosis, Metastatic Sites, Prior Androgen Deprivation Therapy, Baseline Testosterone Level,"
NCT02317744,"Age, Categorical, Age, Continuous, Sex: Female, Male, Region of Enrollment, Binge Eating Frequency, Body Mass Index (BMI), ","Age, sex, BMI, duration of binge eating disorder, number of binge eating episodes per week, current weight, highest weight in the last 12 months, psychiatric comorbidity, baseline depression score, baseline anxiety score, history of medication use, history of substance use, history of eating disorders other than binge eating disorder, baseline blood pressure, baseline heart rate, baseline liver function tests, baseline kidney function tests, fasting glucose, fasting lipid profile.","Age, Sex: Female, Male, BMI (kg/m2), Binge Eating Disorder (BED) diagnosis duration, Number of binge eating episodes per week, Weight (kg), Height (cm), Waist circumference, Depression scale score, Anxiety scale score, Quality of Life scale score, Current medications, Previous treatments for BED","Age Continuous, Sex: Female, Male, Race (NIH/OMB), BMI (kg/m2), Number of Binge Eating Episodes per Week, Duration of Binge Eating Disorder, Current Depression Scale Score, Anxiety Scale Score, Quality of Life Scale, Eating Disorder Examination-Questionnaire (EDE-Q) Global Score, Yale-Brown Obsessive Compulsive Scale Modified for Binge Eating (Y-BOCS-BE), History of Weight Loss Attempts, Medication Use","Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Ethnicity (NIH/OMB), Body Mass Index (BMI), Number of Binge Eating Episodes per Week, Binge Eating Disorder Examination (BEDE) Score, Yale-Brown Obsessive Compulsive Scale (Y-BOCS) Score, Beck Depression Inventory (BDI) Score, State-Trait Anxiety Inventory (STAI) Score"
NCT02451917,"Age, Continuous, Sex: Female, Male, Region of Enrollment, Duration of Diabetes, Body weight, BMI, Systolic Blood Pressure, Diastolic Blood Pressure, ","Age, sex, duration of diabetes, baseline A1c levels, body mass index (BMI), blood pressure, serum creatinine, estimated glomerular filtration rate (eGFR), total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, history of cardiovascular disease, current smoking status, current medication use","Age, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Duration of Diabetes, Body Mass Index (BMI), Glomerular Filtration Rate (GFR), Hemoglobin A1c, Fasting Blood Glucose, Total Cholesterol, LDL Cholesterol, HDL Cholesterol, Triglycerides, Blood Pressure, Number of Participants Using Antihypertensive Medication, Number of Participants Using Lipid-Lowering Medication, Number of Participants Using Antiplatelet Agents","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Duration of Diabetes, Baseline A1c Levels, Baseline Fasting Plasma Glucose, Number of Participants Using Oral Hypoglycemic Agents, Number of Participants with History of Hypoglycemic Events, Stage of Chronic Kidney Disease, Baseline Serum Creatinine, Estimated Glomerular Filtration Rate","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Baseline Hemoglobin A1c, Baseline Fasting Blood Glucose, Baseline Postprandial Blood Glucose, Number of Participants Using Oral Hypoglycemic Agents, Number of Participants with History of Hypoglycemic Events, Stage of Chronic Kidney Disease, Estimated Glomerular Filtration Rate"
NCT02352974,"Age, Categorical, Age, Continuous, Sex: Female, Male, Race and Ethnicity Not Collected, Region of Enrollment, Weight, BMI, Type 1 diabetes duration, GADA (Antibodies to GAD with molecular mass 65,000), Weighted C-peptide, 90-minute C-peptide, Fasting C-peptide, HbA1c, Average insulin dose/kg/24 h, IDAA1c, ","Age, gender, duration of Type 1 diabetes, fasting C-peptide levels, GADA levels, Body Mass Index (BMI), HbA1c (glycated hemoglobin), Vitamin D levels, insulin dose, presence of other autoantibodies, history of diabetes in family, previous adverse reactions to vaccines or drugs, history of immunosuppressant therapy use, history of anti-diabetic medication use other than insulin, history of Vitamin D medication use, history of significant illness, history of alcohol or drug abuse, pregnancy status for females, contraception use, history of significant infections or diseases affecting study participation.","Age, Sex: Female, Male, Body Mass Index (BMI) continuous, Baseline weight, Duration of diabetes, Baseline fasting C-peptide, GADA (Glutamic Acid Decarboxylase Antibodies) levels, Baseline Glycosylated haemoglobin (HbA1c) at baseline, Vitamin D levels at baseline","Age, Continuous, Sex: Female, Male, Duration of Type 1 Diabetes, Fasting C-peptide levels, GADA (Glutamic Acid Decarboxylase Antibodies) levels, Body Mass Index (BMI) continuous, Baseline Insulin Dose, Vitamin D levels","Age, Continuous, Sex: Female, Male, Duration of Type 1 Diabetes, Baseline C-peptide levels, GADA (Glutamic Acid Decarboxylase Antibodies) levels, Body Mass Index (BMI) continuous, Vitamin D levels at baseline"
NCT02347527,"Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, BMI, Baseline food image ratings, ","Age, sex, BMI (Body Mass Index), baseline dietary intake, physical activity level, education level, socioeconomic status, ethnicity, baseline food preferences, baseline neuronal response to food cues, medical history, medication use, smoking status, alcohol consumption.","Age, Sex: Female, Male, BMI (Body Mass Index), Dietary Habits, Baseline Food Image Ratings, Physical Activity Level, Education Level, Income Level, Race/Ethnicity, Customized, Region of Enrollment, Current Medications, Baseline Neuronal Response to Food Cues","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index (BMI), Current Diet Type, Baseline Food Preference, Baseline Food Intake, Baseline Neuronal Response to Food Cues","Age, Continuous, Sex: Female, Male, BMI (Body Mass Index), Dietary Habits, Baseline Food Image Ratings, Baseline Neuronal Response to Food Cues, Physical Activity Level"
NCT04484831,"Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race, Highest Parental Education, BMI, ","Age, sex, baseline BMI, height, weight, waist circumference, body composition, physical activity level, dietary habits, psychological assessment scores (e.g., for depression, anxiety), medical history, medication use, socioeconomic status, education level, family history of obesity or related conditions.","Age, Sex: Female, Male, Ethnicity (NIH/OMB), Body Mass Index (BMI), Weight, Height, Percentile BMI for Age and Sex, Baseline Questionnaire Scores - Quality of Life, Baseline Questionnaire Scores - Mental Health, Baseline Questionnaire Scores - Physical Activity, Baseline Dietary Intake Assessment, Family History of Obesity, Family History of Cardiovascular Diseases, Baseline Medication Use, Baseline Comorbid Conditions","Age, Sex: Female, Male, Race/Ethnicity, Height, Weight, Body Mass Index (BMI), Baseline Physical Activity Level, Baseline Dietary Habits, Baseline Psychological Assessment Scores, Family History of Obesity or Related Conditions, Baseline Medication Use, Baseline Comorbid Conditions","Age, Sex: Female, Race/Ethnicity, BMI Percentile, Weight, Height, Baseline Physical Activity Level, Baseline Dietary Intake, Psychological Well-being Scores, Baseline Medication Use, Parental BMI"
NCT01341301,"Age, Categorical, Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, ","Age, gender, diagnosis of hematologic malignancy, type of hematologic malignancy, stage of disease, prior treatments received (including number of chemotherapy regimens and any prior radiation therapy), time from diagnosis to transplant, Karnofsky Performance Status, hematopoietic cell transplantation comorbidity index (HCT-CI) score, HLA typing results, donor relationship and HLA match level, left ventricular ejection fraction (LVEF), diffusion capacity of the lung for carbon monoxide (DLCO) adjusted for hemoglobin, serum bilirubin levels, aspartate aminotransferase (AST) or alanine aminotransferase (ALT) levels, creatinine clearance, presence of untreated class I or II antibodies against donor HLA antigens, HIV status, involvement of the central nervous system with malignancy, psychiatric status, pregnancy status, life expectancy, previous treatment with alemtuzumab or anti-thymocyte globulin (ATG) levels, presence of active inflammatory processes, ability to tolerate cyclophosphamide or undergo total body irradiation.","Age, Continuous, Sex: Female, Male, Disease Type, Continuous, Disease Stage, Karnofsky Performance Status, Continuous, Number of Prior Treatments, Continuous, Type of Prior Treatment, HLA Typing, Continuous, Donor Relationship, Continuous, Comorbidity Index Score, Continuous, Left Ventricular Ejection Fraction (%), Continuous, Diffusion Capacity of the Lung for Carbon Monoxide (%), Continuous, Serum Bilirubin, Continuous, AST or ALT Level, Continuous, Creatinine Clearance (ml/min), Continuous","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Diagnosis, Disease Stage, Prior Treatments, Karnofsky Performance Status, Hematopoietic Cell Transplantation-Comorbidity Index (HCT-CI), Number of Previous Transplants, Type of Donor, HLA Match/Mismatch, Organ Function Tests (Liver, Kidney, Heart, Lung), Infection Status, Blood Type","Age, Continuous, Sex: Female, Male, Disease Type, Disease Status, Prior Treatment Regimens, Karnofsky Performance Status, HCT-CI Score, Donor Relationship, Donor-Recipient HLA Match, Hemoglobin Level, White Blood Cell Count, Platelet Count, Serum Bilirubin, AST, ALT, Creatinine Clearance, LVEF, DLCO, Contraceptive Use,"
NCT01155050,"Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Region of Enrollment, Diagnosis of diabetes, Diagnosis of hypertension, Use diabetes medication, Use cholesterol medication, Use blood pressure medication, Use anti-depression medication, Low-density lipoprotein, High-density lipoprotein, Triglycerides, systolic blood pressure, diastolic blood pressure, Weight, Body Mass Index, Waist circumference, ","Age, BMI, waist circumference, weight, fasting blood sugar, resting blood pressure, physical activity level, use of medications for diabetes, use of medications for hypertension, presence of a working conventional telephone line, presence of a grounded electrical power supply, duration in LSU HCSD system","Age, Sex: Female, Male, Race/Ethnicity, BMI, Waist circumference, Weight, Blood pressure, Fasting blood sugar, Physical activity level, Current medications for diabetes or hypertension, History of drug or alcohol abuse, History of significant weight loss or gain, History of bariatric surgery, History of major organ transplant, History of cancer treatment, Mental health history, Pregnancy status, Support from health care provider or family members, Ability to use in-home equipment, Access to a working telephone line, Access to grounded electrical power supply","Age, Sex: Female, Male, BMI, Waist Circumference, Weight, Blood Pressure, Fasting Blood Sugar, Physical Activity Level, Medication Use for Diabetes, Medication Use for Hypertension, Presence of Chronic Diseases","Age, Continuous, Sex: Female, Male, Ethnicity, BMI, Waist Circumference, Weight, Blood Pressure, Fasting Blood Sugar, Diabetes Medication Use, Hypertension Medication Use, Physical Activity Level, Smoking Status, Alcohol Consumption"
NCT02362048,"Age, Categorical, Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, ","Age, sex, ECOG performance status, histological type of pancreatic cancer, number of prior systemic chemotherapy regimens, presence of metastases (location and number), baseline tumor size, weight, height, body mass index (BMI), liver function tests (alanine transaminase [ALT], aspartate transaminase [AST], bilirubin), renal function tests (creatinine, glomerular filtration rate [GFR]), complete blood count (CBC) with differential, prior malignancy history, cardiovascular disease history, gastrointestinal function status.","Age, Sex: Female, Male, ECOG Performance Status, Histological Type, Number of Prior Systemic Therapies, Presence of Liver Metastases, Presence of Lung Metastases, Other Metastatic Sites, CA 19-9 Levels, Albumin, Bilirubin, Creatinine, Hemoglobin, Neutrophil-to-Lymphocyte Ratio, Prior Surgical Resection, Prior Radiation Therapy","Age, Categorical, Age, Continuous, Sex: Female, Male, ECOG Performance Status, Region of Enrollment, Number of Prior Systemic Therapies, Histological Type, Presence of Metastases, Location of Metastases, CA 19-9 Levels, Albumin, Bilirubin, Creatinine, Hemoglobin, Neutrophil-to-Lymphocyte Ratio","Age, Continuous, Sex: Female, Male, ECOG Performance Status, Number of Prior Systemic Therapies, Baseline CA 19-9 Levels, Presence of Liver Metastases, Presence of Lung Metastases, Other Site Metastases, Prior Surgical Resection of Pancreatic Cancer, Prior Radiation Therapy, Hemoglobin, Albumin, Total Bilirubin, AST, ALT, Creatinine"
NCT01175473,"Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Area Under Plasma Glucose Concentration Curve From Time 0.5 Hours to 4.5 Hours (GLU-AUC0:30-4:30h), Postprandial Plasma Glucose (PPG) Excursion, Pro-insulin AUC(0:30-4:30h), Insulin AUC(0:30-4:30h), C-Peptide AUC(0:30-4:30h), Glucagon AUC(0:30-4:30h), Glycosylated Hemoglobin (HbA1c), Peptide YY3-36 (PYY3-36) Concentration, Obestatin Concentration, ","Age, sex, body mass index (BMI), duration of type 2 diabetes, baseline HbA1c, fasting plasma glucose, postprandial plasma glucose, insulin levels, pro-insulin levels, C-peptide levels, glucagon levels, blood pressure, lipid profile (total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides), renal function tests (creatinine clearance), liver function tests (alanine aminotransferase, total bilirubin), history of cardiovascular disease, medication use (especially metformin dose), smoking status, alcohol consumption","Age, Sex: Female, Male, Body Mass Index (BMI), Type 2 Diabetes Mellitus duration, HbA1c, Fasting Plasma Glucose, Postprandial Plasma Glucose, Insulin levels, C-peptide levels, Glucagon levels, Blood Pressure (Systolic and Diastolic), Heart Rate, Renal Function Tests (Creatinine Clearance), Liver Function Tests (AST, ALT, Bilirubin), Lipid Profile (Total Cholesterol, LDL, HDL, Triglycerides), History of Cardiovascular Disease","Age, Continuous, Sex: Female, Male, Body Mass Index (BMI), Duration of Type 2 Diabetes, Glycosylated Hemoglobin (HbA1c), Fasting Plasma Glucose, Postprandial Plasma Glucose, Baseline medication use (Metformin), Blood Pressure, Lipid Profile (Total Cholesterol, LDL, HDL, Triglycerides), Renal Function Tests (Creatinine, eGFR), Liver Function Tests (AST, ALT, Bilirubin), Cardiovascular History, Smoking Status","Age, Continuous, Sex: Female, Male, Body Mass Index (BMI), Duration of Type 2 Diabetes, Glycosylated Hemoglobin (HbA1c), Fasting Plasma Glucose, Blood Pressure, Lipid Profile (Total Cholesterol, LDL Cholesterol, HDL Cholesterol, Triglycerides), Renal Function Tests (Creatinine, eGFR), Liver Function Tests (AST, ALT, Bilirubin), History of Cardiovascular Disease, Medication Use (Metformin and other antidiabetic drugs), Smoking Status"
NCT00302003,"Age, Categorical, Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, ","Age, gender, stage of Hodgkin's lymphoma, histology subtype, presence of bulky disease, B symptoms (fever, night sweats, weight loss), baseline blood counts (hemoglobin, white blood cells, platelets), serum creatinine, glomerular filtration rate (GFR), total bilirubin, alanine aminotransferase (ALT), shortening fraction or ejection fraction (from echocardiogram or MUGA scan), QTc interval from ECG, performance status, presence of extranodal disease, prior treatment history, fertility status, pregnancy test result for females of childbearing potential.","Age, Sex: Female, Male, Race (NIH/OMB), Ethnicity (NIH/OMB), Stage of Hodgkin Lymphoma, Histology of Hodgkin Lymphoma, Baseline Creatinine Clearance or GFR, Total Bilirubin, Alanine Aminotransferase (ALT), Cardiac Function (Shortening Fraction or Ejection Fraction), QTc Interval on ECG, Pregnancy Status","Age, Sex: Female, Male, Race, Ethnicity, Stage of Hodgkin Lymphoma, Histology Type, Baseline Creatinine Clearance or GFR, Total Bilirubin, Alanine Aminotransferase (ALT), Cardiac Function (Shortening Fraction or Ejection Fraction), QTc Interval on ECG, Fertility Status, Contraceptive Use,","Age, Continuous, Sex: Female, Male, Race, Ethnicity, Stage of Hodgkin Lymphoma, Histology Type, Baseline Blood Counts (Hemoglobin, White Blood Cells, Platelets), Liver Function Tests (Alanine Aminotransferase [ALT], Bilirubin), Renal Function (Creatinine Clearance or GFR), Cardiac Function (Ejection Fraction or Shortening Fraction), Presence of B Symptoms (fever, night sweats, weight loss), Bulky Disease Status, Number of Involved Nodal Areas, Baseline Tumor Size"
NCT00688701,"Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Glycosylated Hemoglobin (HbA1c), 2-Hour Postprandial Plasma Glucose (PPG), Body Weight, Fasting Plasma Glucose (FPG), Glucose Excursion, Duration of Diabetes, Body Mass Index (BMI), ","Age, sex, duration of diabetes, baseline HbA1c, fasting plasma glucose (FPG), 2-hour postprandial plasma glucose (PPG), body weight, body mass index (BMI), blood pressure (systolic and diastolic), lipid profile (total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides), renal function tests (serum creatinine, estimated glomerular filtration rate (eGFR)), liver function tests (aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase, total bilirubin), hemoglobin, hematocrit, white blood cell count, platelet count, history of cardiovascular disease, history of diabetic complications","Age, Sex: Female, Male, Race/Ethnicity, Body Mass Index (BMI), Duration of Diabetes, Baseline Glycosylated Hemoglobin (HbA1c) levels, Fasting Plasma Glucose (FPG), 2-hour Postprandial Plasma Glucose (PPG), Blood Pressure (Systolic and Diastolic), Lipid Profile (Total Cholesterol, LDL-C, HDL-C, Triglycerides), Renal Function Tests (Serum Creatinine, eGFR), Liver Function Tests (AST, ALT, Total Bilirubin), History of Cardiovascular Disease, History of Diabetic Complications","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, BMI, HbA1c levels, Fasting plasma glucose levels, 2-hour postprandial plasma glucose levels, Body weight, Blood pressure (systolic and diastolic), Lipid profile (total cholesterol, LDL-C, HDL-C, triglycerides), Renal function tests (serum creatinine, eGFR), Liver function tests (AST, ALT, total bilirubin), Hemoglobin levels, Platelet count, Neutrophil count","Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Region of Enrollment, Body Mass Index (BMI), Fasting Plasma Glucose, Glycosylated Hemoglobin (HbA1c), Blood Pressure, Total Cholesterol, LDL Cholesterol, HDL Cholesterol, Triglycerides, Renal Function Tests, Liver Function Tests"
NCT00395512,"Age Continuous, Age, Customized, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Weight, Body Mass Index (BMI), Duration of diabetes, ","Age, sex, body mass index (BMI), duration of diabetes, fasting plasma glucose, glycosylated hemoglobin (HbA1c), fasting C-peptide, systolic blood pressure, diastolic blood pressure, serum creatinine, alanine aminotransferase (ALT), thyroid stimulating hormone (TSH), urine albumin to creatinine ratio, history of antidiabetic therapy use, baseline medication use","Age, Sex: Female, Male, Race/Ethnicity, Body Mass Index (BMI), Glycosylated Hemoglobin (HbA1c), Fasting Plasma Glucose, Duration of Diabetes, Blood Pressure: Systolic, Diastolic, Serum Creatinine, Alanine Aminotransferase (ALT), Fasting C-peptide, Thyroid Stimulating Hormone (TSH), Hemoglobin","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Body Mass Index (BMI), Body Weight, Duration of Diabetes, Glycosylated Hemoglobin (HbA1c), Fasting Plasma Glucose, Fasting C-peptide, Blood Pressure (Systolic and Diastolic), Serum Creatinine, Alanine Aminotransferase (ALT), Thyroid Stimulating Hormone (TSH)","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, BMI, Body Weight, Duration of Diabetes, Fasting Plasma Glucose, Fasting C-peptide, HbA1c"
NCT01192139,"Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Race/Ethnicity, Customized, Height, Weight, Body Mass Index, ","Age, sex, BMI, medical history, physical examination findings, ECG results, clinical laboratory determinations, vital signs, history of gastrointestinal disease, history of significant drug allergies, use of prescription drugs, use of over the counter products, use of herbal preparations, participation in other clinical studies","Age, Sex: Female, Male, Body Mass Index (BMI), Race, Ethnicity, Healthy Subject Status, Vital Signs (Blood Pressure, Heart Rate), Electrocardiogram (ECG) Results, Clinical Laboratory Determinations (Hematology, Biochemistry), Medical History","Age, Sex: Female, Male, Body Mass Index (BMI), Race/Ethnicity, Health Status, Smoking Status, Alcohol Consumption","Age, Continuous, Sex: Female, Male, Body Mass Index (BMI), Race/Ethnicity, Region of Enrollment"
NCT00672243,"Age, Categorical, Age, Customized, Sex: Female, Male, Karnofsky Performance Scale (KPS), Received prior bevacizumab, Enzyme-inducing anti-epileptic drug (EIAED) status, ","Age, gender, Karnofsky performance score, diagnosis (primary WHO grade IV malignant glioma, GBM transformation), prior treatment history (surgical resection, external-beam radiation therapy, chemotherapy), interval since last treatment (surgery, radiation, chemotherapy), hematocrit, absolute neutrophil count (ANC), platelets, serum creatinine, serum glutamic oxaloacetic transaminase (SGOT), bilirubin, fasting plasma triglyceride, fasting cholesterol, corticosteroid dose, use of enzyme inducing antiepileptic drugs (EIAED), prior bevacizumab treatment, reproductive status, pregnancy test result (for women of childbearing potential)","Age, Sex: Female, Male, Karnofsky Performance Score, Histologic Type of Glioma, Prior Treatment History (Surgery, Radiation, Chemotherapy), Interval since Last Treatment, Hematocrit, Absolute Neutrophil Count (ANC), Platelets, Serum Creatinine, Serum Glutamic Oxaloacetic Transaminase (SGOT), Bilirubin, Fasting Plasma Triglyceride, Fasting Cholesterol, Use of Corticosteroids, Use of Enzyme Inducing Antiepileptic Drugs (EIAEDs), Prior Bevacizumab Use","Age, Continuous, Sex: Female, Male, Karnofsky Performance Score, Tumor Histology, Prior Treatment History, Medication Use (EIAED status), Hematocrit, Absolute Neutrophil Count (ANC), Platelets, Serum Creatinine, Serum Glutamic Oxaloacetic Transaminase (SGOT), Bilirubin, Fasting Plasma Triglyceride, Fasting Cholesterol","Age, Continuous, Sex: Female, Male, Karnofsky Performance Score, Tumor Histology, Prior Treatment History, Medication Use, Hematocrit, Absolute Neutrophil Count, Platelets, Serum Creatinine, Serum Glutamic Oxaloacetic Transaminase (SGOT), Bilirubin, Fasting Plasma Triglyceride, Fasting Cholesterol"
NCT01619488,"Age, Categorical, Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Region of Enrollment, Weight, ","Age, Gender, BMI, Duration of Obesity, Previous Weight Loss Attempts, Comorbid Conditions (e.g., diabetes, hypertension), Baseline Psychological Assessment Score, Family Support Level, Baseline Physical Activity Level, Dietary Habits","Age, Sex: Female, Male, BMI, Weight, Height, Obesity Duration, Failed Diet Attempts, Psychological Assessment Outcome, Family Support Level","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index (BMI), Obesity Duration, Previous Weight Loss Attempts, Psychological Evaluation Outcome, Family Support Level, Comorbid Conditions (e.g., Type II Diabetes Mellitus, Hypertension, Dyslipidemia), Baseline Weight, Baseline Height","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index (BMI), Obesity Duration, Previous Weight Loss Attempts, Psychological Evaluation Outcome, Family Support Level"
NCT00370292,"Age Continuous, Sex: Female, Male, Region of Enrollment, Disease Stages, Eastern Cooperative Oncology Group Performance Status, Histopathological Grade, Previous Anti-Tumor Treatment, Previous Surgery, Race/Ethnicity, Tumor Type, Blood Pressure, Body Surface Area (BSA), Body Temperature, Heart Rate, Height, Weight, ","Age, sex, smoking history, histology of NSCLC, stage of disease, performance status on the ECOG Scale, creatinine clearance, presence of brain metastasis, prior chemotherapy regimens, baseline blood counts (hemoglobin, white blood cells, platelets), baseline levels of biomolecules involved in the gemcitabine mechanism (e.g., dCK, hENT expressions), liver function tests (ALT, AST, bilirubin), presence of third-space fluid collections, cardiac function assessment","Age, Sex: Female, Male, Race (NIH/OMB), ECOG Performance Status, Disease stage (IIIB, IV), Histology (Adenocarcinoma, Squamous cell carcinoma, Other), Smoking status (Never, Former, Current), Number of prior chemotherapy regimens, Creatinine Clearance (CrCl), Presence of brain metastasis","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, ECOG Performance Status, Disease stage (IIIB, IV), Histology type, Smoking status, Previous treatments, Creatinine Clearance (CrCl), Body Surface Area (BSA)","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, ECOG Performance Status, Smoking Status, Histology: Adenocarcinoma, Squamous Cell, Other, Stage of Disease: IIIB, IV, Prior Chemotherapy, Creatinine Clearance"
NCT03811093,"Age, Continuous, Sex: Female, Male, Race and Ethnicity Not Collected, Region of Enrollment, Percentage Body Fat, Body Circumference Measurements, Weight of Body Fat, ","Age, sex, body mass index (BMI), waist circumference, hip circumference, waist-to-hip ratio, total body weight, percentage of body fat, history of previous weight loss attempts, baseline physical activity level, dietary habits, presence of comorbid conditions (e.g., diabetes, hypertension), medication use, smoking status, alcohol consumption","Age Continuous, Sex: Female, Male, Body Weight, Height, Body Mass Index (BMI), Body Fat Percentage, Total Body Fat in Pounds, Waist Circumference, Hip Circumference, Total Inches Lost","Age, Sex: Female, Male, Body Weight, Height, Body Mass Index (BMI), Waist Circumference, Hip Circumference, Total Body Fat Percentage, Total Inches Lost","Age, Categorical, Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Region of Enrollment, Body Weight, Height, Body Mass Index (BMI), Body Fat Percentage, Waist Circumference, Hip Circumference, Total Body Water, Lean Body Mass,"
NCT02159703,"Age, Categorical, Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, ","Age, gender, ECOG Performance Status, histologic diagnosis, HPV status, p16 immunohistochemistry result, clinical stage, pathologic T stage, pathologic N stage, presence of lymphovascular invasion, presence of perineural invasion, margin status, smoking history, alcohol consumption, previous treatments for oropharyngeal cancer, baseline toxicity assessment, baseline quality of life assessment","Age, Sex: Female, Male, HPV Status, Smoking History, Alcohol Consumption, Baseline ECOG Performance Status, Tumor Stage, Tumor Grade, Histology Type, Presence of Lymph Node Involvement, Baseline Hemoglobin Level, Baseline White Blood Cell Count","Age, Continuous, Sex: Female, Male, HPV Status, Smoking History, Alcohol Consumption, ECOG Performance Status, Tumor Stage, Pathologic T Category, Pathologic N Category, Baseline Weight, Baseline Height","Age, Continuous, Sex: Female, Male, HPV Status, Smoking History, Alcohol Consumption, ECOG Performance Status, Tumor Stage, Nodal Status, Baseline Weight, Baseline Height"
NCT00989963,"Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Pulmonary Vascular Resistance (PVR), Cardiac Output (CO), Mean Pulmonary Arterial Pressure (mPAP), Six Minute Walk Distance, Borg Dyspnea Score, ","Age, gender, duration of PAH diagnosis, PAH etiology (idiopathic, familial, associated with collagen vascular disease, anorexigen-induced, associated with repaired congenital systemic-to-pulmonary shunts), baseline 6-minute walk test (6MWT) distance, mean Pulmonary Arterial Pressure (PAPm), Pulmonary Capillary Wedge Pressure (PCWP), Pulmonary Vascular Resistance (PVR), right heart cardiac catheterization findings, chest radiograph findings, current PAH medication (ERA and/or PDE-5 inhibitor), time on current PAH medication, World Health Organization (WHO) functional class, body mass index (BMI), smoking status, history of pulmonary embolism or deep venous thrombosis, history of ischemic heart disease, presence of atrial fibrillation, pulmonary function test results (Total Lung Capacity, FEV1/FVC ratio)","Age, Sex: Female, Male, Pulmonary Arterial Hypertension diagnosis type, 6-minute walk test distance, Right Heart Catheterization findings, Pulmonary Arterial Pressure, Pulmonary Capillary Wedge Pressure, Pulmonary Vascular Resistance, Chest radiograph findings, PAH medication history, World Health Organization (WHO) Functional Class, Body Mass Index (BMI), Smoking status","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, PAH Etiology, 6-minute walk test distance, WHO Functional Class, Pulmonary Vascular Resistance, Mean Pulmonary Arterial Pressure, Cardiac Output, Use of ERA and/or PDE-5 inhibitors, Time since PAH diagnosis, Body Mass Index","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, 6-minute walk test distance, Pulmonary Arterial Pressure (PAP), Pulmonary Vascular Resistance (PVR), Cardiac Output (CO), WHO Functional Class, Use of ERA and/or PDE-5 inhibitors, Baseline medication use, Body Mass Index (BMI), Hemodynamics, Oxygen saturation (SpO2)"
NCT01722643,"Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, HbA1c, ","Age, gender, duration of type 1 diabetes, baseline HbA1c, frequency of daily blood glucose monitoring, insulin regimen (type and doses), body mass index (BMI), socioeconomic status, educational level of parents, presence of diabetes-related complications, executive function scores, delay discounting scores, internet usage patterns, family history of type 1 diabetes","Age, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Duration of Type 1 Diabetes, Baseline HbA1c, Average Blood Glucose Monitoring Frequency, Insulin Delivery Method (Pump vs. Injections), Socioeconomic Status, Education Level of Parents/Guardians, Internet Access Quality","Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Region of Enrollment, Duration of Type 1 Diabetes, Baseline HbA1c, Average Blood Glucose Monitoring Frequency, Executive Function, Delay Discounting, Internet Access, Family Structure, Educational Level of Parents, Previous Diabetes Education, Insulin Delivery Method","Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Region of Enrollment, HbA1c, Duration of Type 1 Diabetes, Daily Self-Monitoring of Blood Glucose Frequency, Executive Function Measures, Delay Discounting Measures, Internet Use and Access, Family Structure, Socioeconomic Status, Education Level of Parents, Diabetes Treatment Satisfaction Questionnaire, Diabetes-related Family Conflict, Baseline Insulin Regimen"
NCT02737501,"Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Race/Ethnicity, Customized, Region of Enrollment, Global Health Status/Quality of Life (QoL), ","Age, sex, smoking history, ECOG performance status, stage of disease, number of prior systemic therapies, presence of brain metastases, ALK rearrangement status, measurable lesion per RECIST v1.1, QT interval, organ function parameters, weight, height, baseline PFS","Age, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), ECOG Performance Status, ALK Rearrangement Status, Stage of Disease, Number of Prior Systemic Therapies, Presence of CNS Metastases, QTc Interval, Baseline Pulmonary Function, Hemoglobin, White Blood Cell Count, Platelets, Serum Creatinine, Liver Function Tests (AST, ALT, Bilirubin)","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Eastern Cooperative Oncology Group (ECOG) Performance Status, Number of Prior Treatment Regimens, ALK Rearrangement Status, Tumor Histology, Stage of Disease, Presence of CNS Metastases","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, ECOG Performance Status, ALK rearrangement status, Number of Prior Systemic Therapies, Presence of CNS Metastases, QTc Interval"
NCT00126737,"Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, BMI at Baseline, Duration of OA, Walking Distance, WOMAC Function, 36 Items Short Form Survey Instrument (SF-36v) Mental Scale, SF-36v Physical Scale, Stair Total (climb, descend), Married, ","Age, gender, body mass index (BMI), diagnosis duration of osteoarthritis, Kellgren and Lawrence grade, American Arthritis Association functional class, baseline pain intensity, WOMAC function score, SF-36 Physical Scale score, SF-36 Mental Scale score, current medication use, comorbid conditions","Age, Sex: Female, Male, Body Mass Index, Waist Circumference, WOMAC Pain Score, WOMAC Function Score, Physical Scale SF-36v, Mental Scale SF-36v, Kellgren and Lawrence Grade, American Arthritis Association Functional Class","Age, Sex: Female, Male, Race/Ethnicity, Body Weight, Body Mass Index (BMI), Waist Circumference, Knee Radiograph Grade, American Arthritis Association Functional Class, WOMAC Pain Score, Physical Activity Level,","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Weight, Body Mass Index, Knee Pain Scale, WOMAC Pain Score, WOMAC Function Score, Physical Activity Level, SF-36 Physical Function Score, SF-36 Mental Health Score, Kellgren and Lawrence Grade, American Arthritis Association Functional Class"
NCT01322490,"Age, Categorical, Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Randomization Stratum, ","Age, race, baseline PSA level, Gleason score at diagnosis, number of bone metastases, presence of lymph node metastases, prior treatments for prostate cancer (including types and dates), history of smallpox vaccination, use of GnRH agonists or antagonists, surgical castration status, performance status (e.g., ECOG), hemoglobin level, alkaline phosphatase level, lactate dehydrogenase level, testosterone level, presence of any other significant medical conditions (e.g., cardiovascular disease, diabetes), history of opioid use for cancer-related pain, estimated PSA doubling time.","Age, Continuous, Sex: Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Height, Body Weight, BMI, Prostate-Specific Antigen (PSA) Level, Gleason Score at Diagnosis, Number of Bone Metastases, Lymph Node Involvement, Prior Treatments for Prostate Cancer, Use of GnRH Agonists or Antagonists, Surgical Castration Status","Age, Continuous, Sex: Male, Race/Ethnicity, Customized, Region of Enrollment, PSA level at baseline, Gleason score at diagnosis, Metastatic sites (Bone, Lymph nodes), Prior treatments for prostate cancer, Use of GnRH agonists or antagonists, Performance status (e.g., ECOG), Hemoglobin level, Alkaline phosphatase level, Lactate dehydrogenase (LDH) level, Testosterone level, Prior smallpox vaccination status","Age, Continuous, Sex: Male, Race/Ethnicity, Customized, Region of Enrollment, Prostate-Specific Antigen (PSA) Level, Gleason Score at Diagnosis, Number of Bone Metastases, Lymph Node Involvement, Prior Prostate Cancer Treatments, Chemotherapy Na√Øve, Vaccinia Virus Exposure, Use of GnRH Agonists or Antagonists, Performance Status (e.g., ECOG), Hemoglobin, Alkaline Phosphatase, Lactate Dehydrogenase (LDH), Albumin, Testosterone Level, Number of Participants with Visceral Metastases, Number of Participants with Pain Medication Use, Cardiovascular History, Immunological Status, Autoimmune Disease Status"
NCT00799604,"Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Height, Weight, Screening Blood Pressure, Screening Heart Rate, ","Age, sex, weight, height, body mass index (BMI), history of hypertension, duration of hypertension, current antihypertensive medications, baseline systolic blood pressure (SBP), baseline diastolic blood pressure (DBP), heart rate, type of cardiac surgery planned, renal function (e.g., serum creatinine, estimated glomerular filtration rate (eGFR)), liver function tests (e.g., AST, ALT, bilirubin), lipid profile (e.g., LDL, HDL, total cholesterol, triglycerides), fasting glucose, hemoglobin A1c, smoking status, alcohol use, previous cardiovascular events (e.g., myocardial infarction, stroke), echocardiographic parameters (e.g., left ventricular ejection fraction), presence of diabetes mellitus, presence of chronic kidney disease","Age, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Baseline Systolic Blood Pressure, Baseline Diastolic Blood Pressure, History of Hypertension, Type of Cardiac Surgery Planned, Previous Cardiac Surgery, Medications for Hypertension, Body Mass Index (BMI), American Society of Anesthesiologists (ASA) Physical Status Classification","Age, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Baseline Systolic Blood Pressure, Baseline Diastolic Blood Pressure, History of Hypertension, Type of Cardiac Surgery Planned, Previous Cardiac Surgery, Medication Use for Hypertension","Age, Categorical, Age, Continuous, Gender, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Baseline Systolic Blood Pressure, Baseline Diastolic Blood Pressure"
NCT00877890,"Age, Categorical, Age, Continuous, Sex: Female, Male, Glycosylated hemoglobin (HbA1c), Weight, Background Oral Antidiabetic Agent, ","Age, sex, duration of type 2 diabetes mellitus, baseline HbA1c, body mass index (BMI), fasting plasma glucose, postprandial glucose, lipid profile (total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides), blood pressure, renal function tests (serum creatinine, eGFR), liver function tests (AST, ALT, bilirubin), current antidiabetic medications, history of cardiovascular disease, smoking status, alcohol consumption","Age, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Body Mass Index (BMI), Glycosylated Hemoglobin (HbA1c), Duration of Diabetes, Fasting Serum Glucose, Total Cholesterol, HDL Cholesterol, LDL Cholesterol, Triglycerides, Blood Pressure, Current Medications","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Body Weight, Body Mass Index (BMI), Glycosylated Hemoglobin (HbA1c), Duration of Diabetes, Fasting Serum Glucose, Total Cholesterol, HDL Cholesterol, LDL Cholesterol, Triglycerides, Blood Pressure, Current Medications, Diet and Exercise Regimen","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Body Weight, Body Mass Index (BMI), Glycosylated Hemoglobin (HbA1c), Duration of Diabetes, Fasting Serum Glucose, Current Antidiabetic Medications,"
NCT02926950,"Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Hemoglobin A1c (HbA1c), Systolic Blood Pressure (SBP), ","Age, sex, body mass index (BMI), duration of type 2 diabetes, baseline hemoglobin A1c (HbA1c), fasting plasma glucose (FPG), 2-hour postprandial glucose (PPG), systolic blood pressure (SBP), diastolic blood pressure (DBP), lipid profile (total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides), renal function tests (serum creatinine, eGFR), liver function tests (AST, ALT, total bilirubin), history of cardiovascular disease, current medication use including metformin dose, smoking status, alcohol consumption","Age, Sex: Female, Male, Race/Ethnicity, Body Mass Index (BMI), Hemoglobin A1c, Fasting Plasma Glucose, Systolic Blood Pressure, Diastolic Blood Pressure, Duration of Diabetes, Current Metformin Dose, Education Level, Smoking Status, Cardiovascular Disease History, Renal Function Measures, Liver Function Tests","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Body mass index (kg/m^2), Hemoglobin A1c (%), Fasting plasma glucose (mg/dL), Duration of Type 2 Diabetes (years), Metformin dose (mg/day), Blood pressure (mmHg), Total cholesterol (mg/dL), LDL cholesterol (mg/dL), HDL cholesterol (mg/dL), Triglycerides (mg/dL), Renal function (eGFR mL/min/1.73m^2), Liver function tests (AST, ALT), History of cardiovascular disease (Yes, No)","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, BMI (kg/m^2), Duration of T2D (years), HbA1c (%), Fasting Plasma Glucose (mg/dL), Blood Pressure (mmHg), Total Cholesterol (mg/dL), LDL Cholesterol (mg/dL), HDL Cholesterol (mg/dL), Triglycerides (mg/dL), Renal Function (eGFR mL/min/1.73m^2), Liver Function Tests (AST, ALT), History of Cardiovascular Disease, Medication Use (Type and Dose), Metformin Dose (mg/day)"
NCT00902538,"Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Weight, Height, Body Mass Index, Obesity, ","Age, gender, race/ethnicity, body mass index (BMI), history of hypertension, duration of hypertension, previous antihypertensive medication use, mean trough seated systolic blood pressure (SeSBP), mean trough seated diastolic blood pressure (SeDBP), heart rate, renal function tests (serum creatinine, estimated glomerular filtration rate [eGFR]), liver function tests (aspartate aminotransferase [AST], alanine aminotransferase [ALT], gamma-glutamyltransferase [GGT]), serum potassium, serum sodium, fasting blood glucose, lipid profile (total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides)","Age, Sex: Female, Male, Race, Ethnicity, Body Mass Index (BMI), Baseline Blood Pressure (Seated Systolic Blood Pressure and Seated Diastolic Blood Pressure), Heart Rate, History of Antihypertensive Medication Use, Duration of Hypertension, Serum Creatinine, Serum Potassium, Liver Function Tests (AST, ALT, GGT), Previous Cardiovascular Events","Age, Categorical, Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Baseline Seated Systolic Blood Pressure (SeSBP), Baseline Seated Diastolic Blood Pressure (SeDBP), Number of Antihypertensive Medications at Baseline, Region of Enrollment","Age, Categorical, Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Baseline Seated Systolic Blood Pressure (SeSBP), Baseline Seated Diastolic Blood Pressure (SeDBP), Body Mass Index (BMI), Region of Enrollment, History of Antihypertensive Medication Use"
NCT00623194,"Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Age, Height, BMI, Pubertal Status, ","Age, gender, duration of diabetes, baseline HbA1c levels, insulin dose, body mass index (BMI), fasting blood glucose levels, history of severe hypoglycemia events, history of diabetic ketoacidosis, presence of other autoimmune diseases, previous insulin regimen, antibody levels against insulin detemir and insulin aspart before trial start","Age, Sex: Female, Male, Duration of Diabetes, Baseline Insulin Dose, HbA1c, Body Mass Index (BMI), Fasting Blood Glucose, Insulin Antibodies, History of Hypoglycemia Events, Pubertal Status","Age, Categorical, Sex: Female, Male, Race and Ethnicity Not Collected, Region of Enrollment, Diabetes duration, Baseline insulin dose, HbA1c, Body Mass Index (BMI), Pubertal status","Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Duration of Diabetes, Insulin Dose, Body Mass Index (BMI), HbA1c, Fasting C-Peptide Levels"
NCT03980808,"Age, Categorical, Age, Continuous, Sex/Gender, Customized, Race/Ethnicity, Customized, Region of Enrollment, Deaf, Diabetes Diagnosis (Yes), ","Age, Gender, Duration of Diabetes Diagnosis, HbA1c Levels, Body Mass Index (BMI), Education Level, Employment Status, Diabetes Medication Use, Previous Diabetes Education, Health Literacy Level, Frequency of ASL Use, Cardiovascular Risk Factors, Blood Pressure, Lipid Profile, Kidney Function Tests","Age Continuous, Sex: Female, Male, Deafness duration, Diabetes duration, Diabetes type: Type 1, Type 2, HbA1c level, Fasting blood glucose level, Diabetes medication use: Yes, No, History of diabetes education: Yes, No, ASL fluency level","Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Education Level, Employment Status, Marital Status, Diabetes Type, Diabetes Duration, HbA1c, Blood Pressure, BMI (kg/m2), Smoking Status, Alcohol Consumption, Physical Activity Level","Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Ethnicity (NIH/OMB), Education Level, Employment Status, Diabetes Diagnosis: Yes, No, Duration of Diabetes, HbA1c Level, Diabetes Medication Use: Yes, No, Health Literacy Score, Engagement in Diabetes-Related Health Behaviors"
NCT01973972,"Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Region of Enrollment, Hemoglobin A1c, Body mass index, ","Age, sex, race/ethnicity, duration of diabetes, baseline Hemoglobin A1c, baseline BMI, blood pressure, fasting triglycerides, fasting serum LDL-C, serum creatinine, history of cardiovascular disease, current diabetes medications, history of psychiatric illness or substance abuse, history of kidney disease, history of unstable CHD, current smoking status, physical activity level, dietary habits","Age, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), BMI, Hemoglobin A1c, Type of Diabetes, Duration of Diabetes, Current Diabetes Medications, Blood Pressure, Total Cholesterol, LDL-C, HDL-C, Triglycerides, Kidney Function (e.g., serum creatinine), Education level, Employment status, Marital status, Smoking status","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, BMI, Hemoglobin A1c, Diabetes duration, Medication use, Blood pressure, Lipid profile, Kidney function tests, Smoking status, Physical activity level, Dietary habits","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Body Mass Index (BMI), Hemoglobin A1c, Diabetes duration, Medication use for diabetes, Blood pressure, Serum creatinine, Fasting triglycerides, Fasting serum LDL-C,"
NCT00116831,"Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Pre-study Treatment, Smoking history, Body Mass Index (BMI), Duration of cardiovascular disease, Duration of diabetes, ","Age, gender, duration of type 2 diabetes mellitus (T2DM), baseline HbA1c levels, prior anti-hyperglycemic diabetic therapy, left ventricular ejection fraction (EF), body mass index (BMI), smoking status, history of hypertension, history of dyslipidemia, baseline blood pressure (SBP/DBP), serum creatinine levels, liver function tests (ALT, AST, bilirubin), lipid profile (total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides), history of cardiovascular disease, medication use at baseline (including anti-hyperglycemic agents, antihypertensive drugs, lipid-lowering agents), presence of retinopathy or other diabetes-related complications","Age, Sex: Female, Male, Race/Ethnicity, Type 2 Diabetes Mellitus diagnosis duration, HbA1c level, Body Mass Index (BMI), Previous anti-hyperglycemic therapy, Left ventricular ejection fraction, Coronary artery disease status, Smoking status, Blood pressure, Total cholesterol, LDL cholesterol, HDL cholesterol, Triglycerides, Renal function (e.g., serum creatinine), Liver function tests (ALT, AST, bilirubin), History of cardiovascular events, Medication use (anti-hyperglycemic, lipid-lowering, antihypertensive)","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Type 2 Diabetes Mellitus diagnosis, HbA1c levels, Previous anti-hyperglycemic therapy, Left ventricular ejection fraction, Coronary artery disease status, Prior TZD or PPAR-g agonist exposure, Insulin use in the last 6 months, Blood pressure, Hemoglobin levels, Serum creatinine, ALT, AST, Bilirubin levels, History of cardiovascular events, History of congestive heart failure, History of myopathy or elevated creatine kinase, Contraceptive use in females, BMI","Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Region of Enrollment, body mass index, systolic blood pressure, diastolic blood pressure, hemoglobin A1c, fasting plasma glucose, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, history of diabetes mellitus, duration of diabetes, previous anti-hyperglycemic therapy, left ventricular ejection fraction, history of cardiovascular disease, smoking status"
NCT01202175,"Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Body Mass Index, Starting systolic blood pressure, Starting diastolic blood pressure, ","Age, gender, ethnicity, smoking status, drug abuse history, family history of essential hypertension, baseline SBP, baseline DBP, heart rate, presence of microscopic protein in urine, C-reactive protein levels, current medications, history of bronchial asthma or chronic obstructive pulmonary disease, history of hypersensitivity or allergy to beta-blocker therapy, pregnancy status for female subjects, contraception method for female subjects, pulse rate, evidence of arrhythmias including atrioventricular block.","Age, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Family History of Hypertension, Smoking Status, Drug Use History, Body Mass Index (BMI), Blood Pressure (Systolic and Diastolic), Heart Rate, Medication Use, Region of Enrollment","Age, Categorical, Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Ethnicity (NIH/OMB), Region of Enrollment, Weight, Height, Body Mass Index (BMI), Smoking Status, Drug Use Status, Family History of Hypertension, Baseline Blood Pressure (SBP and DBP), Heart Rate","Age, Categorical, Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Region of Enrollment, Family history of hypertension, Smoking status, Drug use history, Body Mass Index (BMI), Systolic Blood Pressure, Diastolic Blood Pressure, Heart Rate, Pulse Rate, Microscopic protein in urine, C-reactive protein levels,"
NCT00518882,"Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Previous OAD treatment, BMI, Duration of diabetes, HbA1c, Height, Weight, ","Age, sex, duration of diabetes, baseline HbA1c, current OAD regimen (metformin, sulphonylurea, or both), BMI, fasting plasma glucose, lipid profile (total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides), blood pressure, renal function (eGFR), liver function tests (ALT, AST), history of cardiovascular disease","Age, Sex: Female, Male, Race (NIH/OMB), BMI, Duration of Diabetes, Baseline HbA1c, Fasting Plasma Glucose, Ongoing OAD Treatment, Blood Pressure, Lipid Profile (Total Cholesterol, LDL, HDL, Triglycerides), Renal Function Tests, Liver Function Tests, History of Cardiovascular Disease","Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Region of Enrollment, Body Mass Index (BMI), HbA1c, Duration of Diabetes, Current Treatment for Diabetes (Metformin, Sulphonylurea), Blood Pressure, Lipid Profile (Total Cholesterol, LDL, HDL, Triglycerides), Renal Function Tests, Liver Function Tests","Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Body Mass Index (BMI), Baseline HbA1c, Duration of Diabetes, Current OAD Treatment (Metformin, Sulphonylurea),"
NCT02367066,"Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Weight, Height, Body Mass Index, T2DM disease duration, Current Metformin Daily Dose, HbA1c, ","Age, sex, body mass index (BMI), HbA1c level, fasting plasma glucose, duration of type 2 diabetes mellitus, current metformin dose, history of diabetes complications, baseline kidney function tests (e.g., serum creatinine), liver function tests (AST, ALT), hematology profile, clinical chemistry profile, urinalysis results","Age, Sex: Female, Male, BMI, HbA1c, Fasting plasma glucose, Duration of diabetes, Current medication use, Liver function tests (AST, ALT), Kidney function tests (eGFR, serum creatinine), Blood pressure, Lipid profile (total cholesterol, LDL, HDL, triglycerides)","Age, Continuous, Sex: Female, Male, BMI, Fasting plasma glucose, HbA1c, Duration of diabetes, Current medication use, Liver function tests (AST, ALT), Kidney function tests (eGFR, Creatinine), Blood pressure, Heart rate","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), BMI, Fasting plasma glucose, HbA1c, Duration of Type 2 Diabetes, Metformin use, Blood pressure, Lipid profile (Total cholesterol, LDL cholesterol, HDL cholesterol, Triglycerides), Kidney function tests (eGFR, Creatinine), Liver function tests (AST, ALT),"
NCT02059278,"Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Corneal thickness, study eye (Œºm), Corneal thickness, fellow eye (Œºm), Shaffer angle by gonioscopy, study eye, Shaffer angle by gonioscopy, fellow eye, ","Age, gender, race/ethnicity, duration of primary open angle glaucoma or ocular hypertension diagnosis, baseline intraocular pressure (IOP) at 8 AM, 10 AM, and 4 PM, visual field (VF) mean deviation, pattern standard deviation, corrected Snellen visual acuity, central corneal thickness, Shaffer gonioscopic grade, history of antiglaucoma medication use, baseline use of latanoprost 0.005% ophthalmic solution, presence of systemic diseases (e.g., diabetes, hypertension), history of ocular surgery or laser treatment, history of ocular allergy/inflammation, severe blepharitis or uveitis, history of ocular trauma or infection, history of herpes simplex keratitis, current proliferative diabetic retinopathy or age-related macular degeneration status, severe dry eye status, contact lens use in the untreated fellow eye, presence of secondary glaucoma or ocular hypertension, cup-to-disc ratio, history of non-laser glaucoma surgery, history of moderate or severe renal or hepatic impairment, pregnancy status, contraception method (for women of childbearing potential), history of uncontrolled asthma, allergy to benzalkonium chloride, participation in other investigational studies.","Age, Sex: Female, Male, Race/Ethnicity, Visual Acuity, Intraocular Pressure, Central Corneal Thickness, Visual Field Mean Deviation, Cup-to-Disc Ratio, Number of antiglaucoma medications, Lens Status, Gonioscopic Grade, History of ocular surgery or laser treatment, History of ocular allergy/inflammation, History of ocular trauma or infection, History of systemic diseases (e.g., diabetes, hypertension), Use of systemic medications, Pregnancy status, Contraception method, Smoking status","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Visual Acuity, Central Corneal Thickness, Intraocular Pressure, Visual Field Mean Deviation, Cup-to-Disc Ratio, Number of Antiglaucomatous Medications, Lens Status, Gonioscopic Grade, History of Ocular Surgery or Laser Treatment, Baseline Medication Use, Compliance with Study Medication, Smoking Status, Systemic Hypertension, Diabetes Mellitus","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Visual Acuity, Central Corneal Thickness, Intraocular Pressure, Visual Field Mean Deviation, Cup-to-Disc Ratio, Number of antiglaucoma medications, Baseline Intraocular Pressure, Gonioscopic Grade, History of ocular surgery or laser treatment, History of systemic diseases (e.g., diabetes, hypertension), Use of systemic medications that could affect ocular pressure"
NCT00686127,"Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Average pain intensity, Worst pain intensity, ","Age, Body Mass Index (BMI), Duration of breast cancer diagnosis, Type of breast cancer surgery (e.g., lumpectomy, mastectomy), Time since surgery, Baseline pain intensity score, Baseline functional interference score, Current use of pain medication (type and dosage), Presence of comorbid conditions, Previous treatments for neuropathic pain, Employment status, Education level, Marital status, Quality of life score","Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Type of Breast Cancer Surgery (e.g., lumpectomy, mastectomy), Time since surgery, Pain Intensity Score at Baseline, Pain Location, Pain Duration, Previous Pain Management Interventions, Use of Pain Medications at Baseline, Quality of Life Measures, Functional Status, Neuropathic Pain Symptom Inventory Score, Employment Status, Education Level","Age, Continuous, Sex: Female, Ethnicity, Race, Baseline Pain Intensity Score, Duration of Pain, Previous Pain Management Strategies, Type of Breast Cancer Surgery, Time Since Surgery, Breast Cancer Stage at Diagnosis, Current Breast Cancer Status, Use of Adjuvant Therapy (Chemotherapy, Radiation, Hormonal), Physical Functioning, Quality of Life Measures, Neuropathic Pain Symptom Inventory","Age, Continuous, Sex: Female, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Type of Breast Cancer Surgery, Time Since Surgery, Baseline Pain Intensity Score, Baseline Pain Interference Score, Use of Pain Medication, History of Chemotherapy, History of Radiation Therapy"
NCT01149421,"Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Body Mass Index (BMI), Glycosylated Hemoglobin (HbA1c), Body Weight, Duration of Diabetes, Mean Systolic Blood Pressure (SBP), Mean Diastolic Blood Pressure (DBP), Mean Heart Rate (HR), ","Age, gender, body mass index (BMI), duration of type 2 diabetes, baseline glycosylated hemoglobin (HbA1c) level, mean 24-hour systolic blood pressure (SBP), mean 24-hour diastolic blood pressure (DBP), resting heart rate, number of oral antihyperglycemic medications, number of antihypertensive medications, smoking status, history of cardiovascular disease","Age, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Height, Weight, BMI, Blood Pressure (Systolic and Diastolic), Heart Rate, HbA1c, Duration of Diabetes, Current Oral Antihyperglycemic Medications, Number of Antihypertensive Medications, History of Cardiovascular Disease","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, BMI, HbA1c, Fasting Plasma Glucose, Blood Pressure, Heart Rate, Duration of Diabetes, Number and Type of Oral Antihyperglycemic Medications, Number and Type of Antihypertensive Medications, Height, Weight","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Weight, kg, Height, cm, BMI (kg/m^2), Blood Pressure (mmHg), Heart Rate (bpm), Glycosylated Hemoglobin (HbA1c), %, Duration of Diabetes, years, Number of Oral Antihyperglycemic Medications, Number of Antihypertensive Medications"
NCT02965976,"Age, Categorical, Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Region of Enrollment, Neoadjuvant Chemotherapy Status, Self Reported Smoking Status, Diabetes Status, ","Age, sex, weight, height, Body Mass Index (BMI), Eastern Cooperative Oncology Group (ECOG) performance status, history of previous surgeries, history of gastrointestinal diseases, history of duodenal ulcer or fibrosis, history of any allergies, specifically to botulinum toxin or egg, history of chronic medication use, including promotility agents, anticholinergic antispasmodic agents, or chronic narcotic use, smoking status, alcohol consumption, baseline symptoms of nausea and vomiting, baseline gastric emptying time, presence of any psychiatric illness or social situations affecting compliance, pregnancy status for females, baseline quality-of-life scores","Age, Sex: Female, Male, Race (NIH/OMB), ECOG Performance Status, Body weight, Body mass index, Hemoglobin, Type of esophageal cancer, Tumor location, Tumor stage, Previous treatments for esophageal cancer, Comorbidities, Smoking status, Alcohol consumption, Baseline gastric emptying time, Baseline nausea and vomiting frequency, Quality of Life scores","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Eastern Cooperative Oncology Group (ECOG) Performance Status, Tumor Stage, Body Mass Index (BMI), Hemoglobin, Albumin, History of Gastrointestinal Disorders, Preoperative Chemotherapy or Radiotherapy, Smoking Status, Alcohol Consumption, Comorbidities","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Tumor Stage, Tumor Location, Prior Esophageal Surgery, Body Mass Index,"
NCT00497146,"Age, Categorical, Age Continuous, Sex: Female, Male, Baseline RAAS Status, Diabetic Status, Age at Beginning of Long term Follow-up Period, Gender at Beginning of Long term Follow-up Period, ","Estimated glomerular filtration rate (GFR), serum intact parathyroid hormone (iPTH) value, corrected serum calcium level, phosphorous level, serum albumin, left ventricular (LV) ejection fraction, septal wall thickness, use of renin-angiotensin-aldosterone system (RAAS) inhibitors, baseline cardiac magnetic resonance imaging (MRI) findings","Age, Sex: Female, Male, Race/Ethnicity, Customized, Chronic Kidney Disease Stage, Baseline Serum Intact Parathyroid Hormone (iPTH) Level, Baseline Corrected Serum Calcium Level, Baseline Phosphorous Level, Baseline Serum Albumin Level, Left Ventricular Ejection Fraction, Septal Wall Thickness, Baseline Left Ventricular Mass Index (LVMI), Estimated Glomerular Filtration Rate (eGFR), Use of Renin-Angiotensin-Aldosterone System (RAAS) Inhibitors, Duration of Chronic Kidney Disease, Blood Pressure, Heart Rate","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Body Mass Index, Estimated Glomerular Filtration Rate (eGFR), Serum Intact Parathyroid Hormone (iPTH) Level, Corrected Serum Calcium Level, Serum Phosphorus Level, Serum Albumin Level, Left Ventricular Ejection Fraction, Septal Wall Thickness, Presence of Left Ventricular Hypertrophy, Baseline Cardiac Magnetic Resonance Imaging (MRI) Findings, Duration of Chronic Kidney Disease, Use of Renin-Angiotensin-Aldosterone System (RAAS) Inhibitors","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Body Mass Index, Estimated Glomerular Filtration Rate (eGFR), Serum Calcium, Serum Phosphorus, Serum Parathyroid Hormone (PTH) Level, Serum Albumin, Left Ventricular Mass Index (LVMI), Left Ventricular Ejection Fraction, Septal Wall Thickness, History of Cardiovascular Disease, Duration of Chronic Kidney Disease, Blood Pressure, Medication Use (e.g., RAAS inhibitors)"
NCT00258362,"Age, Categorical, Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Histology, ","Age, sex, race/ethnicity, stage of endometrial cancer, histological subtype of endometrial cancer, prior treatment history, performance status (GOG score), measurable or evaluable disease status, absolute neutrophil count, platelet count, hemoglobin level, alkaline phosphatase level, aspartate aminotransferase level, alanine aminotransferase level, bilirubin level, creatinine level, presence of acute hepatitis, presence of peripheral neuropathy, life expectancy, fertility status","Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Performance Status, Hemoglobin, Platelet Count, Absolute Neutrophil Count, Bilirubin, Creatinine, Alkaline Phosphatase, Aspartate Aminotransferase, Alanine Aminotransferase, Tumor Stage, Prior Treatment History","Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Performance status, Tumor stage, Histology type, Prior treatment, Hemoglobin, Absolute neutrophil count, Platelet count, Alkaline phosphatase, Aspartate aminotransferase, Alanine aminotransferase, Bilirubin, Creatinine, Peripheral neuropathy grade, Body mass index, Menopausal status","Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Performance Status, Hemoglobin, Absolute Neutrophil Count, Platelet Count, Creatinine, Bilirubin, Alkaline Phosphatase, Aspartate Aminotransferase, Alanine Aminotransferase, Disease Stage, Prior Treatment History, Tumor Size/Measurements"
NCT00030901,"Age Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Age, Baseline Prostate-Specific Antigen (PSA) - reported by site, ","Age, PSA level, American Urological Association symptom score, number of biopsy cores obtained, time since last biopsy, presence of high-grade prostatic intraepithelial neoplasia, prior daily dietary supplement intake containing selenium, performance status (SWOG), history of malignancy within the past 5 years, use of finasteride or other androgen suppressors","Age, Continuous, Sex: Female, Male, PSA Level, American Urological Association Symptom Score, Number of Biopsy Cores, Time since Last Biopsy, Prior Cancer History, Selenium Supplementation History","Age, Continuous, Sex: Female, Male, PSA Level, Number of Prior Prostate Biopsies, High-Grade Prostatic Intraepithelial Neoplasia Presence, American Urological Association Symptom Score, Selenium Dietary Intake","Age, Continuous, Sex: Male, Ethnicity (NIH/OMB), Race (NIH/OMB), PSA Level, American Urological Association Symptom Score, Selenium Levels, Dietary Supplement Use, History of Cancer"
NCT01489189,"Age, Customized, Sex/Gender, Customized, Race/Ethnicity, Customized, Number of study eyes, Diabetes Type, Duration of Diabetes, Hemoglobin A1c, Prior Myocardial Infarction, Prior Stroke, Arterial Blood Pressure, Visual Acuity, Optical Coherence Tomography Central Subfield Thickness, Presence of Center-Involved Diabetic Macular Edema with Visual Acuity Impairment, Presence of Center-Involved Diabetic Macular Edema Regardless of Visual Acuity, Neovascularization on Clinical Examination, Phakic Lens Status on Clinical Exam, Diabetic Retinopathy Severity, Prior treatment for diabetic macular edema (DME), Prior focal/grid laser treatment for DME, Prior anti-VEGF treatment for DME, ","Age, gender, duration of diabetes, type of diabetes (type 1 or type 2), baseline visual acuity, presence of PDR, previous treatments for diabetic retinopathy, systemic treatments for diabetes (insulin, oral anti-hyperglycemia agents), blood pressure, renal function tests, history of cardiovascular disease, history of renal disease, ocular surgical history, intraocular pressure, lens status (phakic, pseudophakic, aphakic), presence of macular edema, OCT findings, fundus photography findings, visual field test results, history of intravitreal injections (anti-VEGF, corticosteroids), history of panretinal photocoagulation, pregnancy status for women of childbearing potential.","Age, Sex: Female, Male, Race/Ethnicity, Type of Diabetes (Type 1, Type 2), Duration of Diabetes, HbA1c, Blood Pressure, Body Mass Index, Serum Creatinine, eGFR, Lipid Profile, Current Smoking Status, History of Cardiovascular Disease, Best Corrected Visual Acuity, Intraocular Pressure, Presence of Diabetic Macular Edema, Central Subfield Thickness on OCT, Extent of Proliferative Diabetic Retinopathy, Previous Treatments for Diabetic Retinopathy (e.g., laser photocoagulation, intravitreal injections), Use of Anti-VEGF Agents, Use of Insulin or Oral Hypoglycemic Agents, Renal Function Status, Presence of Diabetic Peripheral Neuropathy, Presence of Diabetic Nephropathy, Presence of Diabetic Retinopathy in the Fellow Eye","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Diabetes Mellitus Type (Type 1, Type 2), Duration of Diabetes, HbA1c, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Total Cholesterol, LDL Cholesterol, HDL Cholesterol, Triglycerides, Serum Creatinine, eGFR, History of Cardiovascular Disease, Smoking Status, Anti-diabetic Medications, Anti-hypertensive Medications, Lipid-lowering Medications, Best Corrected Visual Acuity, Intraocular Pressure, Central Subfield Thickness on OCT, Presence of Diabetic Macular Edema, Extent of Proliferative Diabetic Retinopathy, Previous Treatments for Diabetic Retinopathy (Laser, Surgery, Injections), Lens Status (Phakic, Pseudophakic, Aphakic)","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Diabetes Type (Type 1, Type 2), Duration of Diabetes, HbA1c, Blood Pressure (Systolic, Diastolic), Total Cholesterol, Body Mass Index, History of Diabetic Retinopathy Treatment, Visual Acuity Score, Presence of Macular Edema, Central Subfield Thickness, Proliferative Diabetic Retinopathy Severity Level, Previous Panretinal Photocoagulation, Previous Anti-VEGF Injections, Lens Status (Phakic, Pseudophakic, Aphakic), Intraocular Pressure"
NCT01375660,"Age, Customized, Sex/Gender, Customized, Race/Ethnicity, Customized, Region of Enrollment, BMI, HbA1c, Vit D, ","Age, race, BMI, stable weight status, FPG, A1C, circulating 25OHD levels, history of ergocalciferol use and washout period, vitamin D supplement intake, history of kidney stones, hyperparathyroidism, sarcoidosis, hypercalcemia, CKD stage, history of significant metabolic, hepatic, renal, hematological, pulmonary, cardiovascular, gastrointestinal, urological, neurological, psychiatric/psychological disorders, or social circumstances, diagnosis of T2DM during screening or after randomization, need for anti-diabetic medications.","Age, Sex: Male, Race: African American, BMI, Stable weight, Fasting Plasma Glucose, A1C, Circulating 25OHD levels, Oral Glucose Insulin Sensitivity, Vitamin D supplementation history, Ergocalciferol washout compliance, Total daily vitamin D intake, Kidney function tests, Calcium levels, Phosphorus levels, Muscle strength assessment","Age, Continuous, Sex: Male, Race: African American, BMI, Fasting Plasma Glucose, A1C, Circulating 25OHD levels, Oral Glucose Insulin Sensitivity","Age, Continuous, Sex: Male, Race: African American, BMI (Body Mass Index), Weight, Height, Fasting Plasma Glucose, A1C, Circulating 25OHD levels, Calcium, Phosphorus, Creatinine, Estimated Glomerular Filtration Rate (eGFR), Parathyroid Hormone (PTH), Vitamin D intake (dietary and supplemental), Physical activity level, Blood pressure (Systolic and Diastolic)"
NCT01147250,"Age, Continuous, Gender, Race, Ethnicity, Qualifying Acute Coronary Syndrome (ACS) event, Body Mass Index (BMI), Body Weight, Glycosylated Hemoglobin (HbA1c), Duration of Diabetes, ","Age, sex, body mass index (BMI), smoking status, blood pressure, heart rate, fasting plasma glucose, glycosylated hemoglobin (HbA1c), lipid profile (total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides), renal function (serum creatinine, estimated glomerular filtration rate (eGFR)), history of cardiovascular disease, duration of type 2 diabetes, medication use (antidiabetic medications, antihypertensive medications, lipid-lowering medications), urinary albumin/creatinine ratio","Age, Sex: Female, Male, Race and Ethnicity, Region of Enrollment, BMI, Type of Acute Coronary Syndrome (ACS) Event: STEMI, NSTEMI, Unstable Angina, Time Since ACS Event, Type 2 Diabetes Diagnosis: Yes, No, Glycosylated Hemoglobin (HbA1c) Level, Fasting Plasma Glucose, History of Coronary Artery Bypass Graft (CABG), History of Percutaneous Coronary Intervention (PCI), Blood Pressure, Lipid Profile: Total Cholesterol, LDL Cholesterol, HDL Cholesterol, Triglycerides, Renal Function: Creatinine, eGFR, Urinary Albumin/Creatinine Ratio, Medication Use: Anti-diabetic Drugs, Anti-hypertensive Drugs, Lipid-lowering Drugs, Antiplatelet Therapy","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Type of Acute Coronary Syndrome (ACS), Time Since ACS Event, Type 2 Diabetes Diagnosis Duration, Glycosylated Hemoglobin (HbA1c), Body Mass Index (BMI), History of Cardiovascular Disease, Smoking Status, Blood Pressure, Lipid Profile","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Type of Acute Coronary Syndrome Event, Time Since Acute Coronary Syndrome Event, History of Diabetes Mellitus, Glycosylated Hemoglobin A1c (HbA1c), Body Mass Index (BMI), Blood Pressure, Lipid Profile, Renal Function Tests, History of Cardiovascular Disease, Smoking Status, Medication Use (Antidiabetic, Antihypertensive, Lipid-Lowering)"
NCT01454401,"Age, Categorical, Age, Continuous, Sex: Female, Male, Diabetes, Body Mass Index (kg/m2), Presence of neuropathy, Ulcer duration (weeks), Ulcer area, Wagner classification, Biochemistry Haemoglobin, Biochemistry, HbA1c, HbA1c, ","Age, Gender, Type of Diabetes (Type I or Type II), Duration of Diabetes, HbA1c level, Wound duration, Wound area, Wound location, Texas classification of the wound, Perfusion status (toe pressure, TcPO2, palpable foot pulse), Presence of infection, Previous treatments for foot ulcers, Use of off-loading devices, Body Mass Index (BMI), Smoking status, Presence of other diabetic complications (e.g., retinopathy, nephropathy, neuropathy), Medication use (especially those affecting wound healing, such as steroids or immunosuppressants), Hemoglobin level, Compliance with study protocol during the run-in period.","Age, Sex/Gender, Type of Diabetes (Type I, Type II), Duration of Diabetes, HbA1c Level, Wound Duration, Wound Area, Wound Location, Wound Depth, Texas Classification of Wound, Perfusion Status (Toe Pressure, TcPO2), Presence of Palpable Foot Pulse, Baseline Ulcer Size, Baseline Ulcer Depth, Infection Status, Use of Off-loading Devices","Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Type of Diabetes (Type I or Type II), Duration of Diabetes, HbA1c level, Wound duration, Wound area, Wound location, Wound depth, Texas classification of wound, Perfusion status (toe pressure, TcPO2), Presence of palpable foot pulses, Body Mass Index (BMI), Previous wound treatments, Ulcer healing status at follow-up visits, Compliance with off-loading devices","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Type of Diabetes (Type I or Type II), HbA1c Level, Wound Duration, Wound Area, Wound Location, Wound Depth, Texas Ulcer Stage, Perfusion Status (Toe Pressure, TcPO2), BMI, Smoking Status, Previous Ulcer History, Presence of Peripheral Arterial Disease, Presence of Neuropathy, Use of Off-loading Devices"
NCT02338362,"Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Region of Enrollment, Mean intraocular pressure, Mean number of ocular hypotensive medications, Prior laser trabeculoplasty, Mean central corneal thickness, Mean cup-disc ratio, Mean visual field mean deviation, Mean logMAR visual acuity, Diagnosis, ","Age, gender, race/ethnicity, baseline intraocular pressure (IOP) in both eyes, cup:disc ratio in both eyes, Humphrey visual field mean deviation in both eyes, duration of diagnosed ocular hypertension or open-angle glaucoma, history of glaucoma medication use, baseline visual acuity in both eyes, body mass index (BMI), history of systemic corticosteroid use, history of any ocular surgery, history of any refractive surgery.","Age, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Baseline Intraocular Pressure, Cup:Disc Ratio, Humphrey Visual Field Mean Deviation, Duration of Glaucoma/Ocular Hypertension, Number of Glaucoma Medications, Type of Glaucoma Medication, Previous Glaucoma Surgery","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Cup:Disc Ratio, Humphrey Visual Field Mean Deviation, Intraocular Pressure (IOP), Glaucoma Medication Use, History of Glaucoma Surgery","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Intraocular Pressure (IOP), Visual Field Mean Deviation, Cup:Disc Ratio, History of Glaucoma Treatment, Type of Glaucoma"
NCT01423604,"Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Height, Weight, Body mass index (BMI), Body surface area, ","Age, gender, Karnofsky performance status, diagnosis of metastatic pancreatic cancer, number of prior chemotherapy regimens, presence of CNS metastases, history of radiation therapy, history of other active malignancies, ability to swallow, renal function tests, hepatic function tests, bone marrow function tests, duration since last chemotherapy, prior treatment with gemcitabine or alternate chemotherapeutic agents.","Age, Sex: Female, Male, Karnofsky Performance Status, Diagnosis of metastatic pancreatic cancer, Number of prior chemotherapy regimens, Presence of CNS metastases, Radiation therapy history, Other active malignancies, Ability to swallow, Renal function tests, Hepatic function tests, Bone marrow function tests, History of seizures","Age Continuous, Sex: Female, Male, Karnofsky Performance Status, Body Weight, Body Mass Index, Number of Prior Chemotherapy Regimens, Tumor Stage, Presence of Metastases, Baseline Pain Score, Hemoglobin, White Blood Cell Count, Platelet Count, Serum Creatinine, Total Bilirubin, Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST)","Age, Continuous, Sex: Female, Male, Karnofsky Performance Status, Number of Prior Chemotherapy Regimens, Presence of CNS Metastases, Baseline Hemoglobin, Baseline White Blood Cell Count, Baseline Platelet Count, Baseline Serum Creatinine, Baseline Bilirubin, Baseline Alanine Aminotransferase (ALT), Baseline Aspartate Aminotransferase (AST), History of Other Malignancies,"
NCT01565564,"Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Race/Ethnicity, Customized, Region of Enrollment, ","Age, Body Mass Index (BMI), Gestational age at diagnosis, Previous history of gestational diabetes, Family history of diabetes, Ethnicity, Socioeconomic status, Educational level, Pre-pregnancy weight, Weight gain during pregnancy, Blood pressure, Fasting plasma glucose, HbA1c, Total cholesterol, LDL cholesterol, HDL cholesterol, Triglycerides, Previous obstetric history (e.g., previous macrosomia, stillbirth), Smoking status, Physical activity level","Age, Gestational Age at Diagnosis, Pre-pregnancy Weight, Height, Body Mass Index (BMI), Blood Pressure (Systolic and Diastolic), Fasting Plasma Glucose, HbA1c, Previous Gestational Diabetes History, Parity (number of pregnancies), Ethnicity, Education Level, Family History of Diabetes","Age, Continuous, Ethnicity (NIH/OMB), Race (NIH/OMB), Pre-pregnancy Weight, Height, Body Mass Index (BMI), Gestational Age at Diagnosis, Fasting Plasma Glucose, HbA1c, Blood Pressure, Previous Gestational Diabetes, Family History of Diabetes","Age, Continuous, Sex: Female, Ethnicity (NIH/OMB), Race (NIH/OMB), Pre-pregnancy Weight, Height, Body Mass Index (BMI), Gestational Age at Diagnosis, Fasting Plasma Glucose, HbA1c, Blood Pressure, Previous Gestational Diabetes, Family History of Diabetes"
NCT03748420,"Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Presence of cardiovascular disease (CVD), ","Age, gender, race/ethnicity, baseline hemoglobin A1C levels, baseline blood pressure values, baseline LDL cholesterol levels, number and types of medications for diabetes, hypertension, and hyperlipidemia, Epic Medication Adherence score (e-PDC), presence of atherosclerotic cardiovascular disease (ASCVD), 10-year cardiovascular risk score based on the ACC/AHA equation, history of cardiovascular disease diagnoses, insurance coverage status, presence of active cancer or chemotherapy treatment, pregnancy status within the last year, enrollment in hospice, statin adherence issue identified, non-insulin glycemic medication adherence issue identified, blood pressure medication adherence issue identified, number of ICD-10 diagnostic codes for diabetes in the last 2 years, LDL results within 2 years","Age, Sex: Female, Male, Race and Ethnicity, Body mass index (BMI), Clinical criteria met (A1C level, BP values, LDL levels, 10-year CV Risk Score), Medication adherence score (e-PDC), Active medications on EHR, Presence of ASCVD, Diabetes diagnosis, Insurance coverage status, Number of ICD-10 diagnostic codes for relevant conditions, Baseline systolic and diastolic blood pressure, Baseline A1c level, Baseline LDL level","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Insurance Status, Clinical Criteria for Inclusion (A1C levels, BP readings, LDL levels, ASCVD risk score), Medication Adherence Score (e-PDC), Number and type of medications at baseline, Baseline systolic and diastolic blood pressure, Baseline hemoglobin A1c, Baseline LDL cholesterol levels, Diabetes diagnosis status, Hypertension diagnosis status, Hyperlipidemia diagnosis status, Cardiovascular disease diagnosis status","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Insurance Status, Clinical criteria for inclusion (A1C level, BP values, LDL levels, CV Risk Score), Medication Adherence Score (e-PDC), Number of medications, Diabetes diagnosis, Hypertension diagnosis, Hyperlipidemia diagnosis, Cardiovascular disease status"
NCT02755831,"Age, Categorical, Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Region of Enrollment, Pre-Pregnancy BMI, ","Age, prepregnancy BMI, gestational age at enrollment, chronic hypertension status, pregestational diabetes status, twin gestation status, history of preeclampsia, history of eclampsia, history of fetal growth restriction, baseline Apnea Hypopnea Index (AHI), smoking status, alcohol consumption, medication use, previous pregnancies and outcomes, sleep study results (WatchPAT-200), CPAP compliance (for the intervention group), baseline sleep quality and duration.","Age, Gestational Age at Enrollment, Prepregnancy BMI, Race/Ethnicity, History of Hypertension, History of Diabetes, Previous Pregnancy Complications (e.g., preeclampsia, eclampsia, fetal growth restriction), Sleep Study Results (AHI score), Continuous Positive Airway Pressure (CPAP) Use History","Age, Continuous, Age, Customized, Sex: Female, Prepregnancy Body Mass Index (BMI), Gestational Age at Enrollment, History of Chronic Hypertension, History of Pregestational Diabetes, Twin Gestation, History of Preeclampsia in Previous Pregnancies, History of Eclampsia in Previous Pregnancies, History of Fetal Growth Restriction in Previous Pregnancies, Apnea Hypopnea Index (AHI) - baseline, Number of Participants With Prior Diagnosis of OSA,","Age, Continuous, Sex: Female, Prepregnancy Body Mass Index (BMI), Gestational Age at Enrollment, Presence of Chronic Hypertension, Presence of Pregestational Diabetes, Twin Gestation, History of Preeclampsia, History of Eclampsia, History of Fetal Growth Restriction, Apnea Hypopnea Index (AHI)"
NCT00833248,"Age Continuous, Sex: Female, Male, Race (NIH/OMB), Region of Enrollment, Body Weight, Body Mass Index, Gleason Score, Stage of Prostate Cancer, Serum Testosterone Levels, Serum Prostate-Specific Antigen (PSA) Levels, Serum Oestradiol Levels, Prostate Volume, Total International Prostate Symptom Score (IPSS), Quality of Life (QoL) Related to Urinary Symptoms, ","Age, race, baseline prostate volume, PSA level, Gleason score, clinical stage of prostate cancer, testosterone level, history of prostate cancer treatment, comorbid conditions, medication use, body mass index (BMI), blood pressure, heart rate, ECG findings, renal function tests, liver function tests, hemoglobin level, white blood cell count, platelet count","Age, Continuous, Sex: Male, Race (NIH/OMB), Prostate-Specific Antigen (PSA) level (ng/mL), Clinical Stage of Prostate Cancer, Gleason Score, Testosterone Level (ng/dL), Prostate Volume (cc) based on Trans Rectal Ultra Sound (TRUS), Prior Prostate Cancer Treatment, Comorbidities, Body Mass Index (kg/m2)","Age, Continuous, Sex: Male, Race/Ethnicity, Customized, Region of Enrollment, Prostate Volume by Trans Rectal Ultra Sound (TRUS) in cm3, Gleason Score, Serum Testosterone Level (ng/dL), Eastern Cooperative Oncology Group (ECOG) Performance Status (PS), Baseline Prostate-Specific Antigen (PSA) in ng/mL","Age, Continuous, Sex: Male, Race/Ethnicity, Customized, Region of Enrollment, Prostate Volume (cc), Serum Prostate-Specific Antigen (PSA) in ng/mL, Gleason Score at Diagnosis, Clinical Stage, Eastern Cooperative Oncology Group (ECOG) Performance Status (PS), Testosterone Level (ng/dL), History of Cardiovascular Disease, Hypertension, Diabetes"
NCT01887600,"Age, Continuous, Sex: Female, Male, Race (NIH/OMB), History of Diabetes (Type 1 or 2), Iron Repletion at Baseline, Baseline Hemoglobin (Hb) Value, Baseline Estimated Glomerular Filtration Rate (eGFR), Time From Chronic Kidney Disease (CKD) Diagnosis, ","Estimated Glomerular Filtration Rate (eGFR), Hemoglobin (Hb) levels, Ferritin level, Transferrin saturation (TSAT) level, Serum folate level, Serum vitamin B12 level, Alanine aminotransferase (ALT) level, Aspartate aminotransferase (AST) level, Total bilirubin (TBL), Body weight, Blood pressure (BP) values","Age, Sex: Female, Male, Body Mass Index (BMI) continuous, Baseline weight, Baseline Hemoglobin (Hb) level, Estimated Glomerular Filtration Rate (eGFR), Serum ferritin level, Transferrin saturation (TSAT) level, Serum folate level, Serum vitamin B12 level, Alanine aminotransferase (ALT) level, Aspartate aminotransferase (AST) level, Total bilirubin (TBL) level","Age, Continuous, Sex: Female, Male, Body Mass Index (BMI) continuous, Baseline weight, Baseline hemoglobin (Hb) level, Estimated Glomerular Filtration Rate (eGFR), Serum ferritin level, Transferrin saturation (TSAT) level, Serum folate level, Serum vitamin B12 level, Alanine aminotransferase (ALT) level, Aspartate aminotransferase (AST) level, Total bilirubin (TBL) level","Age, Continuous, Sex: Female, Male, Stage of Chronic Kidney Disease, Baseline Hemoglobin (Hb) levels, Estimated Glomerular Filtration Rate (eGFR), Serum Ferritin, Transferrin Saturation (TSAT), Serum Folate, Serum Vitamin B12, Body Weight, Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), Total Bilirubin (TBL)"
NCT00062764,"Age Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Obesity Distribution, 2-hr glucose diabetes mellitus, 2-hr glucose (Impaired glucose tolerance), Metabolic syndrome, Fasting glucose, ","Age, sex, body mass index (BMI), waist circumference, blood pressure, fasting plasma glucose, HbA1c, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, liver enzymes (ALT, AST, ALP, GGT), serum insulin, HOMA-IR (Homeostatic Model Assessment for Insulin Resistance), liver volume, visceral fat volume, total NASH activity score, histological features of liver biopsy (steatosis, lobular inflammation, hepatocellular ballooning), platelet count, prothrombin time, serum albumin, bilirubin levels","Age, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Body Mass Index (BMI), Serum Alanine Aminotransferase (ALT) Levels, Total NASH Activity Score, Liver Histology Findings, Fasting Plasma Glucose, Presence of Diabetes Mellitus, Alcohol Consumption History, Medication Use (anti-diabetic drugs, corticosteroids, estrogens, methotrexate, tetracycline, amiodarone), Liver Volume, Visceral Fat Measurement, Insulin Sensitivity","Age, Customized, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Baseline Serum Alanine Aminotransferase (ALT) Levels, Total NASH Activity Score, Presence of Parenchymal Inflammation, Cellular Injury, Steatosis on Liver Biopsy, Fasting Plasma Glucose, History of Diabetes Mellitus, Use of Anti-Diabetic Drugs, Body Mass Index (BMI), Waist Circumference, Insulin Sensitivity Measures","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Baseline Serum Alanine Aminotransferase (ALT) Level, Total NASH Activity Score, Presence of Diabetes Mellitus, Body Mass Index (kg/m^2), Waist Circumference (cm), Fasting Plasma Glucose, Insulin Sensitivity, Liver Volume, Visceral Fat Area, Liver Histology (Steatosis, Inflammation, Ballooning), Hemoglobin A1c (HbA1c)"
NCT01673191,"Age, Categorical, Age, Continuous, Sex: Female, Male, Race and Ethnicity Not Collected, Region of Enrollment, Best Corrected Visual Acuity, Central Retinal Thickness, Intraocular Pressure, ","Age, Gender, Duration of Diabetes Mellitus, Type of Diabetes Mellitus (Type I or II), Time since cataract surgery, Baseline Best Corrected Visual Acuity in the study eye, Baseline Central Retinal Thickness in the study eye, Baseline Intraocular Pressure in the study eye, Presence of macular edema in the fellow eye, Previous treatments for macular edema, HbA1c level, Blood pressure, History of intraocular pressure increase with steroid use, History of ocular surgeries","Age, Sex: Female, Male, Type of Diabetes Mellitus (Type I, Type II), Duration of Diabetes Mellitus, HbA1c Level, Previous Cataract Surgery Date, Baseline Best Corrected Visual Acuity, Baseline Central Retinal Thickness, Baseline Intraocular Pressure, History of Steroid Response, Presence of Other Ocular Conditions","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Type of Diabetes Mellitus (Type I, Type II), Duration of Diabetes Mellitus, HbA1c, Body Weight, BMI, Intraocular Pressure, Visual Acuity, Central Retinal Thickness","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Type of Diabetes Mellitus (Type I, Type II), Duration of Diabetes Mellitus, HbA1c, Body Mass Index (BMI), Intraocular Pressure, Lens Status (Phakic, Pseudophakic), Visual Acuity, Central Retinal Thickness, History of Prior Ocular Treatment"
NCT01289548,"Age Continuous, Age Continuous, Sex: Female, Male, Sex: Female, Male, Region of Enrollment, Body mass index (BMI), Cold ischemic time, Body mass index (BMI), Relationship, ","Age, sex, body mass index (BMI), baseline plasma creatinine concentration, baseline urinary output, baseline plasma concentration of NGAL, duration of end-stage kidney disease, primary cause of kidney failure, previous renal replacement therapy (dialysis), duration of dialysis, ABO blood type, panel reactive antibody (PRA) level, comorbid conditions (diabetes, hypertension, cardiovascular disease), smoking status, medication use","Age, Sex: Female, Male, Ethnicity (NIH/OMB), Region of Enrollment, Body Weight (kg), BMI (kg/m^2), Baseline Plasma Creatinine Concentration, Baseline Urinary Output, Baseline Plasma NGAL Concentration, Type of Kidney Disease, Duration of Kidney Disease, Previous Renal Replacement Therapy (Hemodialysis/Peritoneal Dialysis), Time on Dialysis, PRA Level, Blood Type","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Body Weight, BMI, Type of Kidney Disease, Duration of Kidney Disease, Previous Renal Replacement Therapy (e.g., dialysis), Duration of Dialysis (if applicable), Baseline Plasma Creatinine, Baseline Urinary Output, Baseline Plasma NGAL, Blood Type, PRA Level, Medication Use","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Body Weight, Height, Body Mass Index (BMI), Blood Type, Panel Reactive Antibody (PRA) Level, Chronic Kidney Disease (CKD) Stage, Estimated Glomerular Filtration Rate (eGFR), Plasma Creatinine, Urinary Output, Plasma NGAL Levels"
NCT00918346,"Age Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diagnosis - worse eyes, Central corneal thickness, ","Age, gender, diagnosis (open angle glaucoma or ocular hypertension), prior use of prostaglandins, baseline intraocular pressure (IOP) in both eyes, best corrected visual acuity, central corneal thickness, history of previous glaucoma surgeries or treatments, lens status (phakic, pseudophakic, aphakic), race/ethnicity, systemic medications that could affect IOP, duration of glaucoma or ocular hypertension diagnosis.","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Diagnosis: Open-Angle Glaucoma, Ocular Hypertension, Baseline Intraocular Pressure (IOP), Previous Prostaglandin Use, Visual Acuity, Central Corneal Thickness, Lens Status (Phakic, Pseudophakic, Aphakic), Eye(s) Affected","Age, Continuous, Sex: Female, Male, Diagnosis: Open-Angle Glaucoma, Ocular Hypertension, Baseline Intraocular Pressure (IOP), History of Prostaglandin Use, Eye Affected: Left, Right, Both, Visual Acuity, Central Corneal Thickness","Age, Continuous, Sex: Female, Male, Diagnosis: Open-Angle Glaucoma, Ocular Hypertension, Baseline Intraocular Pressure (IOP), History of Prostaglandin Use, Visual Acuity, Eye Exam Findings,"
NCT00617305,"Age, Categorical, Age Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race/Ethnicity, Customized, Region of Enrollment, ","Age, sex, weight, diagnosis of PAH (idiopathic, familial, or associated with connective tissue disease, congenital heart defects, drug or toxin use, or HIV), WHO functional class, duration of PAH diagnosis, current PAH treatment (sildenafil or tadalafil dose and duration), hemodynamic parameters (mPAP, PVR, PCWP or LVEDP), pulmonary function test results (total lung capacity, forced expiratory volume in 1 second), 6-minute walk test distance, use of calcium channel blockers or statins (type and duration), HIV status, serum alanine aminotransferase (ALT), serum aspartate aminotransferase (AST)","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Weight, WHO Functional Class, 6-Minute Walk Distance, Pulmonary Vascular Resistance, Mean Pulmonary Artery Pressure, Pulmonary Capillary Wedge Pressure, Left Ventricular Ejection Fraction, Hemoglobin, Serum Alanine Aminotransferase, Serum Aspartate Aminotransferase, Total Lung Capacity, Forced Expiratory Volume in 1 Second, Current Medications (Sildenafil, Tadalafil, Calcium Channel Blockers, Statins), HIV Status","Age, Continuous, Sex: Female, Male, Race/Ethnicity, WHO Functional Class, 6-Minute Walk Distance, Pulmonary Vascular Resistance, Mean Pulmonary Arterial Pressure, Pulmonary Capillary Wedge Pressure, Cardiac Output, Right Atrial Pressure, Systolic Blood Pressure, Diastolic Blood Pressure, Heart Rate, Body Weight, Medication Use (Sildenafil, Tadalafil), Liver Function Tests (ALT, AST), Hemoglobin, Hematocrit, Serum Creatinine","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Weight, Height, WHO Functional Class, 6-Minute Walk Distance, Pulmonary Vascular Resistance, Mean Pulmonary Arterial Pressure, Pulmonary Capillary Wedge Pressure, Right Atrial Pressure, Cardiac Output, Systolic Blood Pressure, Diastolic Blood Pressure, Heart Rate, Oxygen Saturation, Hemoglobin, Serum Alanine Aminotransferase, Serum Aspartate Aminotransferase, Anticoagulant Therapy Status"
NCT00408681,"Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Indication for transplantation, Type of pretransplant conditioning regimen, Graft-versus-host disease (GVHD) prophylaxis regimen, Mucosal denudation, Agents given to prevent GVHD at the time of enrollment, Agents given to treat GVHD more than 3 days before enrollment in the study, Interval from transplantation to start of study product administration, Agents given to treat GVHD within 3 days before or after enrollment, ","Age, sex, diagnosis of primary disease, type of donor (related or unrelated), time from transplantation to onset of GVHD, severity of GVHD, prior treatments for GVHD, baseline stool volume per day, presence of hemorrhage, area of denuded mucosa, estimated creatinine clearance, presence of recurrent or secondary malignancy, baseline laboratory biomarker levels","Age, Sex: Female, Male, Diagnosis of GVHD, Severity of GVHD, Duration of GVHD symptoms, Prior treatments for GVHD, Stool volume per day, Presence of hemorrhage, Area of denuded mucosa, Estimated creatinine clearance, Presence of recurrent or secondary malignancy, Type of transplantation (allogeneic vs. others), Time since transplantation","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Severity of GVHD, Baseline Stool Volume (>500 mL/day), Presence of Hemorrhage in Stool, Area of Denuded Mucosa, Estimated Creatinine Clearance, Presence of Secondary Malignancy, Type of Transplant (Autologous, Syngeneic, Allogeneic), Prior Treatment for GVHD","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Type of Transplant (Autologous, Allogeneic), Donor Type (Related, Unrelated), Severity of GVHD, Baseline Creatinine Clearance, Previous GVHD Treatments"
NCT02615158,"Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Maternal age, Household Poverty Ratio, Maternal Education, Maternal Marital Status, Location (Urban/Semi-Urban), Maternal BMI, Maternal dietary intake, Maternal physical activity, Toddler age, Toddler sex, Toddler race/ethnicity, Toddler Body Mass Index (BMI) Z-score, Toddler dietary intake, Toddler physical activity, ","Toddler's age, Toddler's sex, Mother's age, Mother's BMI, Household income, Education level of mother, Marital status of mother, Number of children in household, Toddler's dietary habits, Toddler's physical activity level, Mother's dietary habits, Mother's physical activity level, History of overweight/obesity in family, Toddler's birth weight, Toddler's current weight and height, Mother's current weight and height, Toddler's sleep duration, Presence of depression in mother, Smoking status of mother, Alcohol consumption of mother","Age of parent, Continuous, Age of child, Continuous, Sex of child: Female, Male, Ethnicity (NIH/OMB) of parent, Race (NIH/OMB) of parent, BMI of parent, Continuous, BMI of child, Continuous, Marital Status of parent, Categorical, Education level of parent, Categorical, Household income, Categorical, Physical activity level of parent, Categorical, Diet quality of parent, Categorical, Physical activity level of child, Categorical, Diet quality of child, Categorical, History of overweight/obesity in family, Categorical, Depression status of parent, Categorical, Number of children in household, Categorical, Employment status of parent, Categorical, Breastfeeding duration, Categorical, Sleep duration of child, Categorical, Screen time of child, Categorical","Age of Parent, Continuous, Sex of Parent: Female, Male, Race (NIH/OMB), Ethnicity (NIH/OMB), Marital Status, Categorical, Education Level, Categorical, Household Income, Categorical, BMI of Parent, Continuous, BMI of Child, Continuous, Physical Activity Level of Parent, Categorical, Dietary Habits of Parent, Categorical, Child's Age, Continuous, Child's Sex: Female, Male, Child's Physical Activity Level, Categorical, Child's Dietary Habits, Categorical","Age of Child, Continuous, Age of Mother, Continuous, Sex of Child: Female, Male, Race (NIH/OMB), Ethnicity (NIH/OMB), Maternal BMI, Continuous, Child's BMI Z-score, Continuous, Household Income, Categorical, Marital Status of Mother, Categorical, Education Level of Mother, Categorical, Physical Activity Level of Mother, Categorical, Dietary Habits of Mother, Categorical, History of Depression in Mother, Categorical"
NCT01523457,"Age, Customized, Sex: Female, Male, ECOG Performance Status, Pancreatic tumour location, Level of CA19.9, Biliary stent, ","Age, sex, ECOG Performance Status, primary tumor location, number of metastatic sites, prior treatments (chemotherapy, biological therapy, radiotherapy), time since last treatment, presence of biliary or gastroduodenal obstruction, baseline glucose metabolism (FDG-PET scan results), baseline laboratory parameters (absolute neutrophil count, platelet count, hemoglobin, creatinine, estimated GFR, bilirubin, AST, ALT), presence of any other malignancy within past two years, sensory peripheral neuropathy grade, cardiac disease history, history of chronic diarrhea, pregnancy status.","Age, Sex: Female, Male, ECOG Performance Status, Disease Status: Metastatic, Locally Advanced Unresectable, Prior Treatment History, Baseline Laboratory Values: Absolute Neutrophil Count, Platelets, Hemoglobin, Serum Creatinine, Bilirubin, AST, ALT, Presence of Biliary or Gastroduodenal Obstruction, Sensory Peripheral Neuropathy Grade, Cardiac Disease Status","Age, Categorical, Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), ECOG Performance Status, Disease Stage, Prior Treatment History, Baseline CA 19-9 Levels, Baseline Glucose Metabolism (FDG-PET), Hemoglobin Level, Absolute Neutrophil Count, Platelet Count, Serum Creatinine, Serum Bilirubin, AST, ALT","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, ECOG Performance Status, Disease Status (Metastatic vs. Locally Advanced Unresectable), Prior Treatment History, Baseline Tumor Measurements, Baseline CA 19-9 Levels, Hemoglobin Level, White Blood Cell Count, Absolute Neutrophil Count, Platelet Count, Serum Creatinine, Bilirubin Level, AST Level, ALT Level, Presence of Biliary or Gastroduodenal Obstruction, Neuropathy Status, Cardiac History"
NCT01126580,"Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Body Weight, Body Mass Index (BMI), Duration of Diabetes, Glycosylated Hemoglobin (HbA1c), ","Age, sex, duration of type 2 diabetes, current diabetes medication, body mass index (BMI), baseline glycosylated hemoglobin (HbA1c) level, fasting plasma glucose, serum creatinine, creatinine clearance, liver function tests, serum calcitonin, blood pressure, heart rate, history of cardiovascular disease, smoking status, alcohol consumption","Age, Sex: Female, Male, Race (NIH/OMB), Ethnicity (NIH/OMB), Duration of Type 2 Diabetes, Current medication use, Body Mass Index (BMI), Glycosylated Hemoglobin (HbA1c), Fasting Plasma Glucose, Serum Creatinine, Creatinine Clearance, Liver Function Tests, Pancreatic Function Tests, Blood Pressure, Heart Rate, History of Cardiovascular Disease, Self-Monitored Blood Glucose (SMBG) readings, Previous and concurrent medication use","Age, Continuous, Sex/Gender, Customized, Ethnicity (NIH/OMB), Race (NIH/OMB), Duration of Diabetes, Baseline Glycosylated Hemoglobin (HbA1c), Body Mass Index (BMI), Current Medication Use, History of Diabetes Medication Use, Blood Pressure, Serum Creatinine Levels","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Body Mass Index (BMI), Duration of Diabetes, Baseline Glycosylated Hemoglobin (HbA1c), Current Medication Use, Blood Pressure, Lipid Profile, Kidney Function Tests"
NCT03011567,"Age, Categorical, Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Gestational age, ","Age, Body Mass Index (BMI), Gestational age at delivery, Type of hypertensive disorder of pregnancy (gestational hypertension, preeclampsia without severe features, preeclampsia with severe features, HELLP syndrome, eclampsia), Previous pregnancies and outcomes, Baseline blood pressure measurements, Serum creatinine, Liver function tests (AST, ALT), Platelet count, Use of antihypertensive medications prior to delivery, Severity of hypertension (if applicable), Presence of comorbid conditions, Smoking status, Alcohol use","Age, Gestational Age at Delivery, Blood Pressure (Systolic, Diastolic), Mean Arterial Pressure, Type of Hypertensive Disorder of Pregnancy, Proteinuria, Serum Creatinine, Liver Enzymes (AST, ALT), Platelet Count, Weight, Height, BMI, Previous Pregnancy History, Medication Use during Pregnancy, NSAID Use Postpartum","Age, Continuous, Sex: Female, Gestational Age at Delivery, Type of Hypertensive Disorder of Pregnancy, Blood Pressure Measurements, Height, Weight, Body Mass Index, Previous Pregnancy History, Medication Use During Pregnancy","Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Gestational Age at Delivery, Blood Pressure, Type of Hypertensive Disorder of Pregnancy, Use of Antihypertensive Medications, Serum Creatinine, Platelet Count, Liver Function Tests (AST, ALT)"
NCT04281784,"Age, Categorical, Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, ","Age, sex, race/ethnicity, primary diagnosis, comorbid conditions, baseline functional status, cognitive status, prior hospitalizations within the last year, ICU admissions within the last year, living situation (e.g., home, assisted living, nursing home), current medications, baseline symptom burden, health care utilization history, advance directive status, palliative care history, enrollment in hospice care, patient-reported quality of life, caregiver status, socioeconomic status, insurance type.","Age, Sex: Female, Male, Type of chronic illness, Severity of illness, Previous hospital admissions, Length of stay in hospital, ICU use history, Previous goals-of-care discussions, Baseline functional status, Comorbid conditions, Medication use, Health care utilization history, Living situation (e.g., home, assisted living), Palliative care history, DNR status (Do Not Resuscitate), Cognitive function status","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Diagnosis, Serious Illness Criteria, Palliative Care Needs, Previous Hospital Admissions, ICU Use History, Length of Stay in Hospital, Previous Goals-of-Care Discussions, Comorbidity Index, Baseline Functional Status, DNR Status","Age, Continuous, Sex: Female, Male, Diagnosis, Serious Illness Criteria, Charlson Comorbidity Index, Baseline EHR Documentation of Goals of Care Discussions, ICU Use History, Hospital Admission Frequency, Length of Stay in Hospital, Baseline Quality of Life Measures, Palliative Care History, DNR Status (Do Not Resuscitate), Health Care Utilization History"
NCT03479697,"Age, Categorical, Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, ","Age, gender, race/ethnicity, baseline systolic blood pressure, baseline diastolic blood pressure, body mass index (BMI), cardiovascular risk score, history of cardiovascular diseases, smoking status, alcohol consumption, physical activity level, dietary habits, medication use (including anti-hypertensive, anti-depressant, opiate, benzodiazepine, anti-psychotic, thyroid medications, and sleep medications), seizure disorder history, pregnancy status, hearing ability.","Age, Sex: Female, Male, Race (NIH/OMB), Body weight, Body-mass index (BMI), Systolic blood pressure, Diastolic blood pressure, Heart rate, Medication use (antihypertensive, antipsychotic, antidepressants, thyroid medications), Smoking status, Alcohol consumption, Recreational drug use, Cardiovascular risk score, History of cardiovascular diseases","Age, Sex: Female, Male, Race (NIH/OMB), Ethnicity (NIH/OMB), Body weight, Body-mass index (BMI), Systolic Blood Pressure, Diastolic Blood Pressure, Heart Rate, Cardiovascular Risk Score, Smoking Status","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Cardiovascular Risk Score"
NCT01362790,"Age, Categorical, Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Count of Participants with a Peritoneum and Pleural Tumor Site, ","Age, gender, race/ethnicity, performance status (ECOG), histological type of mesothelioma (epithelial, biphasic), percentage of sarcomatoid component in biphasic tumors, mesothelin expression level, prior chemotherapy regimens, prior targeted therapy (for lung adenocarcinoma cohort), presence of measurable disease, lesion size, total bilirubin level, leukocyte count, absolute neutrophil count, hemoglobin level, platelet count, AST/ALT levels, creatinine level or creatinine clearance, history of major surgery, radiation therapy, chemotherapy, biologic therapy, hormonal therapy, history of allergic reactions to similar compounds, history of invasive malignancy, HIV status, Hepatitis B and C status, serum neutralization antibody assay results, pregnancy status, contraception use, ability to comply with study requirements","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Performance Status (ECOG), Histology of Tumor, Mesothelin Expression Level, Number of Prior Chemotherapy Regimens, Type of Prior Chemotherapy, Total Bilirubin, Continuous, AST/ALT Ratio, Continuous, Creatinine Clearance, Continuous, Presence of Brain Metastases, Disease Stage, Measurable Disease, Continuous","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Performance status (ECOG), Histology of tumor: Epithelial, Biphasic (with ‚â§50% sarcomatoid component), Mesothelin expression in tumor, Continuous, Prior chemotherapy regimens, Number, Total Bilirubin, Continuous, AST/ALT ratio, Continuous, Creatinine or Creatinine Clearance, Continuous, Hemoglobin, Continuous, Platelet count, Continuous, Leukocyte count, Continuous, Absolute neutrophil count, Continuous, Disease stage at enrollment, Customized, Measurable disease, Yes/No, Prior surgical history, Yes/No, Prior radiation therapy, Yes/No, Prior immunotherapy, Yes/No, Prior hormonal therapy, Yes/No, Contraceptive use, Yes/No, Enrollment BMI, Continuous","Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Region of Enrollment, Eastern Cooperative Oncology Group (ECOG) Performance Status, Disease Stage, Histology, Prior Treatment Regimens, Number, Mesothelin Expression Level, Total Bilirubin, Continuous, Aspartate Aminotransferase (AST)/Alanine Aminotransferase (ALT) Levels, Continuous, Creatinine or Creatinine Clearance, Platelet Count, Hemoglobin Level, Absolute Neutrophil Count (ANC)"
NCT00868192,"Age, Continuous, Sex: Female, Male, Region of Enrollment, Stage, Histology, Tumor grade, Pathologic diagnosis, Gynecologic Oncology Group (GOG) Performance Status, Prior number of chemotherapy regimens, Platinum-free interval, ","Age, sex, race/ethnicity, GOG performance status, histologic subtype of ovarian or primary peritoneal carcinoma, number of prior chemotherapy regimens, presence of measurable disease, size of target lesions, baseline CA-125 levels, renal function (creatinine clearance), hepatic function (bilirubin, AST, alkaline phosphatase), hematologic parameters (absolute neutrophil count, platelets), neurologic function (neuropathy grade), coagulation parameters (INR, PTT), blood pressure, history of cardiovascular disease, history of other invasive malignancies, history of abdominal fistula or gastrointestinal perforation, proteinuria status (urine protein-creatinine ratio), history of hypersensitivity to trial drugs","Age, Gender, Race/Ethnicity, GOG performance status, Histologic subtype, Number of prior chemotherapy regimens, Platinum sensitivity, Presence of measurable disease, Lesion size, Blood pressure, Creatinine clearance, Hepatic function (bilirubin, AST, alkaline phosphatase), Neuropathy grade, Coagulation parameters (PT, INR, PTT), Proteinuria, Prior therapy with bevacizumab or pemetrexed, Prior surgical history, Presence of ascites or third space fluid, History of cardiovascular disease, History of CNS disease","Age, Sex: Female, Performance status (e.g., GOG performance status), Histology of tumor, Presence of measurable disease, Number of prior chemotherapy regimens, Prior platinum-based chemotherapy, Prior taxane-based chemotherapy, Blood pressure, Creatinine clearance, Hepatic function (bilirubin, AST, alkaline phosphatase), Neuropathy (sensory and motor), Coagulation parameters (PT/INR, PTT), Proteinuria, Body mass index","Age, Continuous, Sex: Female, Performance status, Histology of tumor, Number of prior chemotherapy regimens, Presence of measurable disease, GOG performance status, Creatinine clearance, Hepatic function, Neuropathy level, Coagulation profile, Blood pressure, Proteinuria status"
NCT00112294,"Age, Continuous, Age, Customized, Sex: Female, Male, Race/Ethnicity, Customized, Eastern Cooperative Oncology Group (ECOG) Performance Status (PS), Weight, ","Age, sex, race/ethnicity, smoking history, performance status, histology of non-small cell lung cancer, stage of disease, number of metastatic sites, prior surgeries, baseline laboratory values (hemoglobin, white blood cell count, platelet count, serum creatinine, liver function tests), presence of CNS metastases, weight, height, body mass index (BMI), ECOG (Eastern Cooperative Oncology Group) performance status, presence of any comorbid conditions.","Age, Sex: Female, Male, Race (NIH/OMB), Smoking status, Performance status (e.g., ECOG), Histology of lung cancer, Stage of disease, Number of prior treatments, Presence of measurable disease, Prior radiation therapy, Prior surgery, Baseline serum tumor markers, Hemoglobin level, White blood cell count, Platelet count, Serum creatinine, Liver function tests (AST, ALT, Bilirubin), Electrolytes (Sodium, Potassium, Chloride), Albumin, Alkaline phosphatase, Lactate dehydrogenase, Eastern Cooperative Oncology Group (ECOG) performance status, Weight, Height, Body Mass Index (BMI), Presence of CNS metastases, Peripheral neuropathy grade, Concurrent medications","Age, Continuous, Sex/Gender, Customized, Race/Ethnicity, Customized, Smoking status, Pack-years of smoking, Performance status (e.g., ECOG), Tumor histology, Stage of disease, Prior surgery, Prior radiation therapy, Measurable disease, Baseline serum creatinine, Baseline liver function tests, Hemoglobin level, White blood cell count, Platelet count, Presence of CNS metastases, Baseline neuropathy grade, Use of anticonvulsants, Use of corticosteroids for CNS metastases, Contraceptive use in women of childbearing potential, Pregnancy status","Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Ethnicity (NIH/OMB), Smoking Status, Performance Status (e.g., ECOG), Tumor Histology, Stage of Disease, Prior Surgery, Prior Radiation Therapy, Weight (kg), Body Mass Index (BMI), Hemoglobin, White Blood Cell Count, Platelet Count, Serum Creatinine, Liver Function Tests (AST, ALT, Bilirubin), Albumin, Eastern Cooperative Oncology Group (ECOG) Performance Status, Presence of Measurable Disease, Presence of CNS Metastases"
NCT00258674,"Age, Categorical, Age, Continuous, Sex: Female, Male, number of patients with HbA1c <9 percent, Number of patients with LDL cholesterol <100mg/dL, Number of patients with blood pressure <130/80 mmHg, Mean HbA1c level, mean LDL level, mean diastolic blood pressure, mean systolic blood pressure, number of patients with annual HbA1c assessment (as determined from medical record review), Number of patients with an annual lipid assessment (as determined from medical record review), Number of patients with annual blood pressure assessment (as determined from medical record review), Number of patients with an annual eye exam (as determined from medical record review), Number of patients with an annual foot exam (as determined from medical record review), Number of patients with annual renal function test (as determined from medical record review), Number of patients with annual HbA1c assessment (as determined from Medicare claims data), Number of patients with an annual eye exam (as determined from Medicare claims data), Number of patients with an annual lipid assessment (as determined from Medicare claims data), Number of patients with a semi-annual HbA1c assessment (as determined form Medicare claims data), ","Age, gender, race/ethnicity, duration of diabetes mellitus, baseline HbA1c levels, baseline LDL levels, baseline blood pressure, history of cardiovascular disease, current diabetes medications, body mass index (BMI), smoking status, history of diabetes-related complications, Medicare insurance plan type, number of diabetes-related visits in the past year, residency status in Texas.","Age, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), State of Residence, Duration of Diabetes, Height, Weight, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Hemoglobin A1c, Low-Density Lipoprotein (LDL) Cholesterol, Medicare Insurance Status","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Duration of Diabetes, Height, Weight, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, HbA1c Level, LDL Cholesterol, Blood Pressure","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Duration of Diabetes, Hemoglobin A1c, LDL Cholesterol, Systolic Blood Pressure, Diastolic Blood Pressure, Body Mass Index, Insurance Type: Medicare"
NCT03887299,"Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Region of Enrollment, Medical Condition, Delivery complications, Vertical Skin incision, Skin closure with staples, ","Age, BMI, gestational age at delivery, previous cesarean deliveries, comorbidities (e.g., diabetes, hypertension), smoking status, previous wound infections, type of cesarean delivery (planned vs. emergency), antibiotic prophylaxis received, duration of labor, duration of rupture of membranes, intraoperative blood loss, type of anesthesia used","Age, Gestational Age at Delivery, Body Mass Index (BMI) at Admission, Previous Cesarean Deliveries, Pre-existing Medical Conditions, Baseline Wound Status, History of Wound Infections, History of Diabetes Mellitus, Smoking Status, Use of Steroids for Lung Maturity, Baseline Hemoglobin/Hematocrit","Age, Gestational Age at Delivery, Pre-pregnancy Weight, Pre-pregnancy Body Mass Index, Admission Body Mass Index, Previous Cesarean Deliveries, Comorbid Conditions (e.g., Diabetes, Hypertension), Smoking Status, Ethnicity, Race","Age, Continuous, Sex: Female, Gestational Age at Delivery, Body Mass Index, Previous Cesarean Delivery, Incision Type, Presence of Diabetes (Type 1, Type 2, Gestational), Hypertension (Chronic, Gestational), Intraoperative Antibiotic Prophylaxis, Estimated Blood Loss"
NCT01329939,"Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Height (cm), Weight (kg), BMI, ","Age, gender, body mass index (BMI), baseline asthma severity, baseline ACT scores, history of asthma, duration of asthma diagnosis, current asthma medications, frequency of asthma exacerbations in the past year, pulmonary function test results (e.g., FEV1), markers of inflammation (e.g., eosinophil count, FeNO levels), allergic status (e.g., presence of atopic conditions), and socioeconomic status.","Age, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), BMI (Body Mass Index), Asthma Severity Level, Duration of Asthma Diagnosis, Number of Asthma Exacerbations in the Past Year, Current Asthma Medication Use, Pulmonary Function Test Results, Allergy Status, Atopic Status, ACT (Asthma Control Test) Scores","Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Region of Enrollment, BMI (Body Mass Index), Asthma Severity Level, Number of Asthma Exacerbations in the Past Year, Current Asthma Medication Use, Pulmonary Function Test Results, Asthma Control Test (ACT) Scores","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, BMI (Body Mass Index), Asthma Severity Classification, Number of Asthma Exacerbations in the Past Year, Pulmonary Function Test Results, Allergic Rhinitis Status, Atopic Dermatitis Status"
NCT05718466,"Age, Continuous, Sex: Female, Male, Race and Ethnicity Not Collected, Diagnosis, Neoadjuvant RT Dose, Neoadjuvant Chemotherapy, On-Trial Chemotherapy, ","Age, sex, performance status (e.g., Karnofsky Performance Status), tumor histology, prior treatment regimens (type and number), time since last treatment, tumor size, tumor location, presence of neurological symptoms, baseline Mini-Mental State Examination (MMSE) score, baseline diffusion-weighted imaging (DWI) parameters, baseline blood counts, baseline renal and liver function tests, baseline coagulation profile","Age, Sex: Female, Male, Performance Status (e.g., Karnofsky Performance Status), Histology of Tumor, Prior Treatment Regimens, Time from Initial Diagnosis, Tumor Location, Tumor Size, Presence of Neurological Symptoms, Use of Corticosteroids, Molecular Markers (e.g., MGMT promoter methylation status), Baseline Mini-Mental State Examination (MMSE) Score","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Karnofsky Performance Status, Tumor histology, Tumor location, Prior treatment regimens (type and number), Time from initial diagnosis, Presence of measurable disease, Baseline tumor size, Number of lesions, Use of corticosteroids, Anticonvulsant use, Mini-Mental State Examination score, Blood pressure, Hemoglobin levels, White blood cell count, Platelet count, Creatinine levels, Liver function tests (AST, ALT, bilirubin)","Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Performance Status (e.g., Karnofsky or ECOG), Tumor Histology, Prior Treatment Regimens, Baseline Neurologic Function, Baseline Tumor Size, Location of Tumor, Presence of Edema, Use of Corticosteroids, Baseline Mini-Mental State Examination (MMSE) Score"
NCT02750410,"Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Percentage of Hemoglobin A1c (HbA1c) at Baseline, Percentage of Participants with Insulin regimen, ","Age, sex, duration of type 2 diabetes, baseline HbA1c, fasting plasma glucose, postprandial plasma glucose, body mass index (BMI), weight, insulin regimen type, daily insulin dose, number of oral antidiabetic drugs (OADs), types of OADs, history of cardiovascular disease, renal function parameters, liver function tests, thyroid function tests","Age, Sex: Female, Male, Duration of Type 2 Diabetes, HbA1c, Body Mass Index (BMI), Weight, Height, Insulin Therapy Type, Oral Antidiabetic Drugs (OADs) Use, Blood Pressure, Lipid Profile (Total Cholesterol, LDL, HDL, Triglycerides), Renal Function Tests, Liver Function Tests","Age, Categorical, Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Region of Enrollment, Duration of Type 2 Diabetes, HbA1c, Body Mass Index (BMI), Weight, Height, Baseline Insulin Regimen, Number of Oral Antidiabetic Drugs (OADs), Average Daily Dose of Insulin","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Body Mass Index (BMI), Hemoglobin A1c (HbA1c), Duration of Diabetes, Type of Insulin Regimen, Daily Insulin Dose, Oral Antidiabetic Drugs (OADs) Use, Weight, Height"
NCT03334214,"Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race/Ethnicity, Customized, Liver Fat Percentage (Randomized Population), Liver Fat Percentage (Per Protocol Population), ","Age, Gender, BMI, Hemoglobin A1c (HbA1c) levels, Duration of Type 2 Diabetes, Liver fat content by MRI-PDFF, History of medication use (Oral Antidiabetic Therapy), Blood pressure, Serum creatinine, Liver enzymes (ALT, AST), Lipid profile (Total cholesterol, LDL cholesterol, HDL cholesterol, Triglycerides), Thyroid-stimulating hormone (TSH), History of cardiovascular disease, Smoking status, Alcohol consumption","Age, Continuous, Sex: Female, Male, Race and Ethnicity Not Collected, Body Mass Index (BMI), Hemoglobin A1c (HbA1c), Duration of Type 2 Diabetes, Current Antidiabetic Medications, Liver Fat Content by MRI-PDFF, Fasting Plasma Glucose, Fasting Insulin, Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), Lipid Profile (Total Cholesterol, LDL Cholesterol, HDL Cholesterol, Triglycerides), Liver Enzymes (ALT, AST, ALP, GGT), Platelet Count, Renal Function Tests (Creatinine, eGFR), Thyroid-Stimulating Hormone (TSH), History of Cardiovascular Disease, Blood Pressure (Systolic BP, Diastolic BP), Heart Rate","Age, Continuous, Sex: Female, Male, Race and Ethnicity (NIH/OMB), Body Mass Index (BMI), Type 2 Diabetes Mellitus Diagnosis Duration, Hemoglobin A1c (HbA1c), Fasting Plasma Glucose, Total Cholesterol, LDL Cholesterol, HDL Cholesterol, Triglycerides, Liver Fat Content by MRI-PDFF, Hepatic Enzymes (ALT, AST, ALP), Albumin, Total Bilirubin, Creatinine, Estimated Glomerular Filtration Rate (eGFR), Blood Pressure (Systolic and Diastolic), Heart Rate, Medication Use (Oral Antidiabetic Drugs, Statins, Other Cardiovascular Medications), History of Cardiovascular Disease","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Body Mass Index (BMI), Type 2 Diabetes Mellitus Diagnosis, Hemoglobin A1C (HbA1c) Level, Duration of Type 2 Diabetes, Oral Antidiabetic Therapy, Liver Fat Percentage by MRI-PDFF, Liver Enzymes (ALT, AST, ALP), Total Bilirubin, Albumin, Creatinine, Blood Urea Nitrogen (BUN), Fasting Plasma Glucose, Fasting Insulin, Insulin Resistance (HOMA-IR), Lipid Profile (Total Cholesterol, LDL, HDL, Triglycerides), Platelet Count, Coagulation Parameters (INR, aPTT), History of Cardiovascular Disease, Smoking Status"
NCT01421667,"Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Pathological Diagnosis, Transformed Disease from Prior Non-Hodgkin Lymphoma, Disease Stage, Bulky Disease (‚â•5 cm on at least one baseline index lesion), Eastern Cooperative Oncology Group Performance Status (ECOG), % CD30 Expression by Visual Immunohistochemistry (vIHC), Refractory to Frontline Therapy, Disease Status Relative to Most Recent Prior Therapy, ","Age, gender, ECOG performance status, number of prior systemic therapies, histological subtype of NHL, CD30 expression level, disease stage at baseline, presence of B symptoms, measurable disease size, prior treatment regimens, time since last treatment, lymph node involvement, extranodal involvement, serum lactate dehydrogenase (LDH) levels, hemoglobin level, white blood cell count, platelet count, presence of comorbid conditions","Age, Gender, Body Weight, Body Mass Index (BMI), Eastern Cooperative Oncology Group (ECOG) performance status, Histological subtype of lymphoma, Number of prior systemic therapies, CD30 expression level, Disease stage, Measurable disease size, Lactate dehydrogenase (LDH) levels","Age, Continuous, Gender, ECOG Performance Status, Disease Stage, Number of Prior Systemic Therapies, CD30 Expression Level, B symptoms (fever, night sweats, weight loss), Lactate dehydrogenase (LDH) level, Bulky disease status, Histological subtype, Presence of extranodal disease, Bone marrow involvement","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Eastern Cooperative Oncology Group (ECOG) Performance Status, Number of Prior Systemic Therapies, CD30 Expression Level, Histological Subtype of Non-Hodgkin Lymphoma, Disease Stage at Enrollment, Measurable Disease Status, Lactate Dehydrogenase (LDH) Level"
NCT02846779,"Age, Continuous, Sex: Female, Male, Race and Ethnicity Not Collected, Region of Enrollment, Hemoglobin A1c, At least 1 HbA1c value available, Short or rapid-acting insulin use, Number of basal insulin claims, Use of adjunct oral hypoglycemic, Hypoglycemia, Ketoacidosis, Retinopathy, Nephropathy, Neuropathy, Coronary artery disease, Hypertension, Hyperlipidemia, Congestive heart failure, Stroke/Transient ischemic attack, Obesity, Asthma/COPD, Cancer, Liver Disease, Chronic Kidney Disease, Depression, Dementia, Acute Stress, Days hospitalized, Number of Hospitalizations, Number of Office visits, ","Age, gender, duration of diabetes, baseline HbA1c levels, insulin regimen (type and dose), comorbid conditions, previous adherence to medication, socioeconomic status, education level, body mass index (BMI), smoking status, alcohol consumption, physical activity level, diabetes-related complications.","Age, Sex: Female, Male, Race (NIH/OMB), Insurance Type, Duration of Diabetes, Basal Insulin Use Duration, HbA1c Level, Number of Diabetes Medications, Adherence to Diabetes Medication (Baseline), Hypoglycemic Events, Hospitalizations","Age, Categorical, Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Type of Diabetes, Duration of Diabetes, Baseline HbA1c, Insulin Usage, Days of Physical Activity, Body Mass Index (BMI), Weight, Height","Age, Continuous, Sex: Female, Male, Insurance Type, Duration of Diabetes, Basal Insulin Use: Yes, No, Hemoglobin A1c, Medication Adherence Score, Number of Diabetes Medications,"
NCT01822925,"Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Body Mass Index (BMI), Height, Weight, ","Age, gender, duration of diabetes, type of diabetes (Type I or Type II), HbA1c level, duration of diabetic neuropathic pain, average pain score, BMI (Body Mass Index), presence of any other neuropathic pain, history of drug or alcohol abuse, history of malignant disease, presence of renal, hepatic, hematologic, active auto-immune or immune diseases, blood biochemistry analyte results, HIV/AIDS status, NYHA Class of congestive heart failure, pregnancy status, use of effective birth control method, diagnosis of psychiatric disorders, use of local anesthetic shot or systemic steroids, adherence to pharmacologic and non-pharmacologic pain management techniques","Age, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Type of Diabetes (Type I, Type II), Duration of Diabetes, HbA1c Level, Duration of Diabetic Neuropathy, Baseline Pain Score, BMI (Body Mass Index), Current Medications for Diabetic Neuropathy, Previous Treatments for Diabetic Neuropathy, Region of Enrollment","Age, Continuous, Sex: Female, Male, Race (NIH/OMB), BMI, Type of Diabetes (Type I, Type II), Duration of Diabetes, HbA1c, Duration of Diabetic Neuropathy, Baseline Pain Score, Likert NRS, Medication Use for Diabetic Neuropathy, Previous Treatments for Diabetic Neuropathy, Presence of other Diabetic Complications","Age, Continuous, Sex: Female, Male, Body mass index (BMI), Type of diabetes (Type I, Type II), Duration of diabetes, HbA1c, Duration of neuropathic pain, Pain score (NRS), Use of analgesics, Serum creatinine, eGFR (estimated Glomerular Filtration Rate), Neuropathy severity score"
NCT00328172,"Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Race/Ethnicity, Customized, Body Mass Index (BMI), Baseline glycosylated hemoglobin (HbA1c), Fasting blood plasma glucose (FPG), ","Age, gender, duration of Type 2 diabetes, baseline HbA1c level, BMI, fasting plasma glucose, previous antidiabetic medication use, renal function (serum creatinine), hepatic function (alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase levels), cardiovascular disease history, central nervous system disease history, psychiatric disorder history, history of allergy/hypersensitivity, history of alcohol or drug abuse, reproductive status in pre-menopausal women","Age, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), BMI (Body Mass Index), Duration of Diabetes, Baseline HbA1c, Fasting Plasma Glucose, Previous Diabetes Medication Use, Renal Function (eGFR), Liver Function Tests (ALT, AST, ALP), Cardiovascular Disease History, Blood Pressure, Lipid Profile (Total Cholesterol, LDL, HDL, Triglycerides)","Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Region of Enrollment, BMI (Body Mass Index), Weight, Height, Type of Diabetes, Duration of Diabetes, Previous Diabetes Medication Use, HbA1c (Glycosylated Haemoglobin), Fasting Plasma Glucose, Blood Pressure systolic (BPs), Blood Pressure diastolic (BPd), Total Cholesterol, LDL Cholesterol, HDL Cholesterol, Triglycerides, Serum Creatinine, Liver Function Tests (ALT, AST, ALP), Urine Albumin-to-Creatinine Ratio, History of Cardiovascular Disease, Smoking Status","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Body mass index (BMI), Duration of Diabetes, Previous antidiabetic medication, Fasting plasma glucose, Glycosylated haemoglobin (HbA1c), Blood pressure systolic (BPs), Blood pressure diastolic (BPd), Total cholesterol, LDL cholesterol, HDL cholesterol, Triglycerides, Serum creatinine, Liver function tests (AST, ALT, ALP), Urine albumin-to-creatinine ratio, History of cardiovascular disease, Smoking status"
NCT02863445,"Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Nulligravid, BMI, Weight (lbs), ","Age, BMI, weight, height, regularity of menstrual cycle, baseline progesterone level, liver function tests, renal function tests, smoking status, current medications, history of metabolic disorders, history of hormonal contraception use within the last 8 weeks, involvement in weight loss programs","Age, Continuous, Sex: Female, Ethnicity (NIH/OMB), Region of Enrollment, Body weight, Height, Body mass index (BMI), Waist circumference, Menstrual cycle regularity, Progesterone level, Smoking status, Alcohol consumption, Physical activity level, Dietary habits, Previous use of emergency contraception, Previous use of hormonal contraception, Liver function tests, Renal function tests, Thyroid function tests, Blood pressure, Pulse rate, History of metabolic disorders, History of Polycystic Ovarian Syndrome (PCOS), Pregnancy test results","Age, Continuous, Sex: Female, Race (NIH/OMB), BMI, Weight, Height, Waist circumference, Hip circumference, Waist-to-hip ratio, Menstrual cycle regularity, Last menstrual period, Progesterone level, Smoking status, Alcohol consumption, Physical activity level, Medical history, Medication use, Contraceptive history, Pregnancy history, Breastfeeding status","Age, Continuous, Sex: Female, Race (NIH/OMB), BMI, Weight, Height, Waist circumference, Hip circumference, Waist-to-hip ratio, Menstrual cycle regularity, Baseline progesterone level, Smoking status, Alcohol consumption, Physical activity level, Medical history, Medication use, Pregnancy history, Contraceptive history,"
NCT01222767,"Age, Categorical, Age, Continuous, Sex: Female, Male, Race and Ethnicity Not Collected, Region of Enrollment, ECOG PS, Tumor diagnosis, Primary location at diagnosis, Metastatic disease, Time from diagnosis to first infusion, Time from last disease progression to first infusion, Sites of disease at diagnosis, Prior radiotherapy, Prior Antitumor surgery (palliative or curative), Prior Systemic anticancer therapy, ","Age, sex, ECOG performance status score, histological subtype of EFT, number of prior chemotherapy regimens, presence of metastatic disease, location of primary tumor, measurable lesion status, radiographic documentation of disease progression, absolute neutrophil count, platelet count, hemoglobin level, creatinine clearance, total bilirubin, alanine aminotransferase level, aspartate aminotransferase level, alkaline phosphatase level, albumin level, left ventricular ejection fraction, serum pregnancy test result (for women of childbearing potential), method of contraception","Age, Sex: Female, Male, ECOG Performance Status, Disease Type (Ewing's Sarcoma, Primitive Neuroectodermal Tumor, Askin's Tumor, Extraosseous Ewing's Sarcoma), Number of Prior Chemotherapy Regimens, Time Since Last Treatment, Measurable Lesion Presence, Hemoglobin Level, Absolute Neutrophil Count, Platelet Count, Creatinine Clearance, Total Bilirubin, Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), Alkaline Phosphatase, Albumin Level, Left Ventricular Ejection Fraction","Age, Continuous, Sex: Female, Male, ECOG Performance Status, Prior Chemotherapy Regimens, Tumor Type (Ewing's Sarcoma, PNET, Askin's Tumor, EOE), Disease Stage, Measurable Lesion Presence, Hemoglobin Level, Absolute Neutrophil Count, Platelet Count, Creatinine Clearance, Total Bilirubin, ALT, AST, Alkaline Phosphatase, Albumin, Left Ventricular Ejection Fraction, Time Since Last Treatment","Age, Sex: Female, Male, ECOG Performance Status, Tumor Type (Ewing's Sarcoma, PNET, Askin's Tumor, EOE), Prior Chemotherapy Regimens, Measurable Lesion Presence, Hemoglobin Level, Absolute Neutrophil Count, Platelet Count, Creatinine Clearance, Total Bilirubin, ALT, AST, Alkaline Phosphatase, Albumin, Left Ventricular Ejection Fraction"
NCT00266695,"Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diabetes Type, Duration of Diabetes, Body Mass Index, Number of Diabetic Retinopathy (DR) Study Eyes Per Participant, Visual Acuity (VA) Score, Blood Pressure, ","Age, gender, duration of diabetes, baseline HbA1c levels, baseline blood pressure, history of cardiovascular disease, baseline visual acuity, presence of macular edema, previous treatments for diabetic retinopathy, renal function tests, lipid profile, body mass index (BMI)","Age, Sex: Female, Male, Duration since completion of B7A-MC-MBCM study, Visual acuity, Diabetic retinopathy severity level, Glycated hemoglobin (HbA1C), Blood pressure, Body Mass Index (BMI), Duration of diabetes, Previous treatments for diabetic retinopathy","Age, Continuous, Sex: Female, Male, Duration of diabetes, Prior ruboxistaurin treatment, Visual acuity score, Stage of diabetic retinopathy, HbA1C, Blood pressure, Body Mass Index (BMI),","Age, Continuous, Sex: Female, Male, Duration since completion of B7A-MC-MBCM study, Visual acuity, History of diabetic retinopathy treatment, Stage of diabetic retinopathy, HbA1C, Blood pressure, Body Mass Index (BMI),"
NCT02603809,"Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Weight, Body Mass Index, Duration of essential hypertension at screening, Antihypertensive treatment at screening, ","Age, sex, race/ethnicity, body mass index (BMI), duration of hypertension, baseline sitting systolic blood pressure (SiSBP), baseline sitting diastolic blood pressure (SiDBP), number of antihypertensive medications being taken, smoking status, alcohol consumption, history of cardiovascular disease, renal function parameters, liver function parameters, fasting blood glucose, lipid profile","Age, Sex: Female, Male, Race/Ethnicity, Body mass index, Baseline sitting systolic blood pressure, Baseline sitting diastolic blood pressure, Heart rate, Serum creatinine, Estimated GFR, Fasting plasma glucose, Total cholesterol, LDL cholesterol, HDL cholesterol, Triglycerides, Current smoker - yes/no, Alcohol consumption - yes/no, Previous antihypertensive treatment - yes/no, Number of antihypertensive medications, 24-hour ambulatory systolic blood pressure, 24-hour ambulatory diastolic blood pressure, Use of statins - yes/no, Use of aspirin - yes/no","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Body Mass Index, Baseline blood pressure (systolic and diastolic), Heart rate, Serum creatinine, Estimated GFR, Fasting plasma glucose, Total cholesterol, HDL cholesterol, LDL cholesterol, Triglycerides, Current antihypertensive medication use, Number of antihypertensive medications, Smoking status - no. (%), Alcohol consumption - no. (%), 24-hour ambulatory blood pressure monitoring (ABPM) systolic and diastolic, Region of Enrollment","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Body Mass Index, Baseline sitting systolic blood pressure, Baseline sitting diastolic blood pressure, Serum creatinine, Fasting plasma glucose, Total cholesterol, HDL cholesterol, LDL cholesterol, Triglycerides, Current smoker - yes/no, Alcohol consumption - yes/no, Previous antihypertensive medication use, Number of antihypertensive medications, 24-hour ambulatory systolic blood pressure, 24-hour ambulatory diastolic blood pressure"
NCT01643382,"Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration dialysis, Duration diabetes, Hemoglobin A1C, Preoperative diabetic regimen, ","Age, gender, duration of diabetes, type of diabetes, HbA1c levels, body mass index (BMI), previous renal function measures (e.g., serum creatinine, glomerular filtration rate), history of cardiovascular disease, blood pressure, lipid profile, immunosuppressive regimen details, duration of end stage renal disease, previous transplant history, dialysis status (type and duration), fasting blood glucose levels, C-peptide levels, insulin regimen before transplant.","Age, Sex: Female, Male, Ethnicity (NIH/OMB), Race/Ethnicity, Customized, Type of Diabetes (Type 1, Type 2), Duration of Diabetes, Previous Glycemic Control (e.g., HbA1c levels), Body Mass Index (BMI), Renal Function (e.g., eGFR, serum creatinine), Dialysis Status (Yes, No), Previous Transplant (Yes, No), Time on Transplant Waiting List, Immunosuppressive Medication Use, Geographic Region","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Type of Diabetes, Duration of Diabetes, Baseline HbA1c, Body Mass Index (BMI), Previous Renal Function, Dialysis Status, Type of Dialysis, Duration of Dialysis, Previous Transplant, Baseline Serum Creatinine, Baseline Glucose Levels","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Type of Diabetes, Duration of Diabetes, Baseline Serum Creatinine, Baseline Glomerular Filtration Rate (GFR), HbA1c, Body Mass Index (BMI), Previous Transplant, Dialysis Status"
NCT03796689,"Age, Continuous, Sex/Gender, Customized, Race/Ethnicity, Customized, Subjective Social Status, Eligibility systolic BP, Eligibility diastolic BP, Satisfaction with BP management, Comfort using technology like a computer or smartphone, ","Age, gender, race/ethnicity, baseline systolic blood pressure, baseline diastolic blood pressure, history of hypertension, duration of hypertension, current blood pressure medications, number of blood pressure medications, body mass index (BMI), arm circumference, smoking status, alcohol consumption, comorbid conditions (e.g., diabetes, cardiovascular disease), previous use of home blood pressure monitoring, smartphone ownership type (Android or iOS), baseline physical activity level, dietary salt intake","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Weight, BMI, Arm Circumference, Systolic Blood Pressure, Diastolic Blood Pressure, Current Blood Pressure Medication Use, Smartphone Ownership, English Literacy Level","Age Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Hypertension Stratification, Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP), Body Mass Index (BMI), Current Medications, Smartphone Ownership, English Literacy Level","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Baseline Systolic Blood Pressure, Baseline Diastolic Blood Pressure, Hypertension Medication Use, Smartphone Ownership Type, Body Mass Index (BMI), Arm Circumference"
NCT03299244,"Age, Continuous, Age, Customized, Sex: Female, Male, Race/Ethnicity, Customized, Stratification Factor: Screening Intact Parathyroid Hormone (iPTH), Stratification Factor: Screening Corrected Calcium (cCa), Stratification Factor: Country/Region, Intact Parathyroid Hormone Level, Corrected Calcium Level, Phosphorus Level, Corrected Calcium Phosphorus Product (cCa x P), ","Age, gender, duration of hemodialysis, baseline serum intact PTH levels, baseline serum calcium levels, baseline serum phosphorus levels, baseline serum albumin levels, baseline dialysis adequacy (Kt/V), baseline urea reduction ratio, use of vitamin D sterols (type and dose), use of calcium supplements (type and dose), use of phosphate binders (type and dose), history of cardiovascular disease, baseline serum magnesium levels, baseline serum transaminase levels (ALT, AST).","Age, Sex: Female, Male, Duration of Hemodialysis, Serum Intact Parathyroid Hormone Level, Serum Calcium Level, Serum Phosphorus Level, Dialysis Adequacy (Kt/V), Urea Reduction Ratio, Use of Vitamin D Sterols, Use of Calcium Supplements, Use of Phosphate Binders, Serum Albumin Level, Serum Magnesium Level, Serum Transaminase Levels, Race/Ethnicity, Body Mass Index (BMI), Tobacco Consumption Status","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Duration of Hemodialysis, Serum Intact Parathyroid Hormone Level, Serum Calcium Level, Serum Phosphorus Level, Dialysis Adequacy (Kt/V), Serum Albumin Level, Baseline Medication Use (Phosphate Binders, Vitamin D Sterols, Calcium Supplements), Tobacco Use Status","Age, Categorical, Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Duration of Hemodialysis, Serum Parathyroid Hormone Level, Serum Calcium, Serum Phosphorus, Dialysis Adequacy (Kt/V), Serum Albumin, Serum Magnesium, Serum Transaminase Levels"
NCT02834663,"Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Duration of Diabetes Mellitus(DM) (year), HbA1c(%), BCVA (ETDRS letters), CRT (um), Total microaneurysms (number), Microaneurysm-turnover, Perifoveal non-perfused area (mm^2), ","Age, gender, duration of diabetes, type of diabetes, baseline Best Corrected Visual Acuity (BCVA), baseline Central Macular Thickness (CMT), baseline microaneurysm count, perifoveal non-perfusion area, presence of mild-to-moderate nonproliferative diabetic retinopathy (NPDR), presence of diabetic macular edema (DME), HbA1c levels, blood pressure, history of previous ocular treatments, lens status","Age, Sex: Female, Male, Race/Ethnicity, Type of Diabetes, Duration of Diabetes, HbA1c, Blood Pressure, Best Corrected Visual Acuity, Central Macular Thickness, Presence of Macular Edema, Severity of NPDR, Previous Treatments for DR","Age, Sex: Female, Male, Ethnicity, Race, Type of Diabetes, Duration of Diabetes, HbA1c, Blood Pressure, Lipid Profile, Body Mass Index (BMI), Best Corrected Visual Acuity (BCVA), Central Macular Thickness (CMT), Presence of Diabetic Macular Edema, Severity of NPDR","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Type of Diabetes, Duration of Diabetes, HbA1c, Blood Pressure, Lipid Profile, Body Mass Index, Best Corrected Visual Acuity, Central Macular Thickness, Region of Enrollment, Smoking Status"
NCT02961920,"Age, Categorical, Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Region of Enrollment, body mass index, ","Age, sex, BMI, ASA physical status, history of smoking, baseline PaO2, baseline hemodynamics (heart rate, blood pressure), history of respiratory or cardiovascular diseases, medication use, duration of surgery, type of surgery (spine surgery specifics), baseline dynamic compliance (Cdyn), peak airway pressure.","Age, Sex: Female, Male, Body Mass Index (BMI), ASA classification, Baseline PaO2, Baseline hemodynamics (heart rate, blood pressure), History of pulmonary disease, Smoking status","Age, Continuous, Sex: Female, Male, BMI, ASA Physical Status Classification, Smoking Status, Baseline PaO2, Baseline Hemodynamics (Blood Pressure, Heart Rate), History of Pulmonary Disease","Age, Continuous, Sex: Female, Male, Body Mass Index (BMI), ASA Physical Status, Past Medical History, Smoking Status, Alcohol Use"
NCT01385098,"Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, BMI, kg/m^2, Body weight, lb, Excess body weight, lb, Surgery type, ","Age, sex, BMI, baseline serum 25(OH)D levels, baseline serum calcium levels, baseline serum phosphorus levels, baseline parathyroid hormone (PTH) levels, type of bariatric surgery (Roux-en Y gastric bypass or sleeve gastrectomy), dietary vitamin D intake, dietary calcium intake, comorbidities, baseline renal function (GFR), history of vitamin D supplementation, sun exposure habits","Age, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), BMI, Type of Bariatric Surgery (Roux-en Y gastric bypass, Sleeve gastrectomy), Baseline Vitamin D [25(OH)D] levels, Baseline Parathyroid Hormone (PTH) levels, Baseline Calcium levels, Baseline Phosphorus levels, Dietary Vitamin D intake, Dietary Calcium intake","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Region of Enrollment, Body Mass Index (BMI), Serum 25(OH)D levels, Parathyroid Hormone (PTH) levels, Serum Calcium, Serum Phosphorus, Dietary Vitamin D intake, Dietary Calcium intake","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Body Mass Index (BMI), Baseline Serum 25(OH)D Levels, Baseline Serum Calcium Levels, Baseline Serum Phosphorus Levels, Baseline Parathyroid Hormone (PTH) Levels"
NCT01805089,"Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Cancer Stage, Smoking Status, Body Mass Index (BMI), Estradiol, Insulin-like Growth Factor 1, Sleep (Pittsburgh Sleep Quality Index), Hot Flashes, Mood, ","Age, Body Mass Index (BMI), Menopausal status, History of breast cancer (type and stage), Time since breast cancer diagnosis, Previous treatments for breast cancer, Current medications, Baseline plasma estradiol levels, Baseline IGF levels, Sleep quality, Frequency of hot flashes, Mood status, Presence of any comorbid conditions","Age, Menopausal Status, Breast Cancer History, Prior Malignancies, Use of Hormonal Therapy, Use of Sleep Aids, Shift Work Status, Use of Supplements (Black Cohosh, Flaxseed, Soy), Use of Oral Melatonin, Use of Warfarin, Seizure Disorder Status","Age, Categorical, Sex: Female, Menopausal status, History of breast cancer (type and stage), Prior cancer treatments (chemotherapy, radiation, surgery), Current medication use, Sleep quality assessment, Hot flash frequency, Mood assessment, Baseline plasma estradiol levels, Baseline IGF levels, BMI (Body Mass Index), Physical activity level, Dietary supplement use (black cohosh, flaxseed, soy), Use of sleep aids, Working night shifts frequency, Compliance with study medication","Age, Categorical, Sex: Female, Menopausal Status, History of Breast Cancer, Stage of Breast Cancer, Prior Breast Cancer Treatment, Use of Sleep Aids, Use of Hormonal Supplements, Use of Melatonin Supplements, Working Night Shifts, Use of Anticoagulants, Use of Anti-epileptic Medication"
NCT01167179,"Age, Categorical, Age, Continuous, Sex: Female, Male, Region of Enrollment, Psychosocial adjustment, Quality of Life, ","Age, gender, type of head and neck cancer, stage of cancer at diagnosis, treatment modality (surgery, radiation, chemotherapy), time since treatment completion, comorbidities, smoking status, alcohol consumption, employment status, marital status, education level, baseline Psychosocial Adjustment to Illness-Scale score","Age, Sex/Gender, Race/Ethnicity, Marital Status, Education Level, Employment Status, Type of Head and Neck Cancer, Stage of Cancer, Treatment Received, Smoking Status, Alcohol Use, Previous Psychiatric History","Age, Sex: Female, Male, Marital Status, Education Level, Employment Status, Type of Head and Neck Cancer, Stage of Cancer, Treatment Received (Surgery, Radiation, Chemotherapy), Smoking Status, Alcohol Use, Quality of Life Scores, Psychosocial Adjustment Scores","Age, Sex: Female, Male, Marital Status, Education Level, Employment Status, Type of Head and Neck Cancer, Stage of Cancer, Treatment Received (Surgery, Radiation, Chemotherapy), Smoking Status, Alcohol Use, Quality of Life Scores, Psychosocial Adjustment Scores, Cognitive Function, Physical Function, Emotional Function"
NCT03544307,"Age, Categorical, Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Region of Enrollment, Blood epinephrine levels, Blood norepinephrine levels, Arterial stiffness, Systolic Blood Pressure, Diastolic Blood Pressure, Hand grip strength, Leg strength, ","Age, sex, body mass index (BMI), blood pressure (systolic and diastolic), resting heart rate, blood epinephrine levels, blood norepinephrine levels, pulse wave velocity (PWV), history of menopause (years since onset), current medication use, smoking status, alcohol consumption, physical activity level","Age, Continuous, Sex: Female, Menopausal status, Blood pressure: Systolic, Blood pressure: Diastolic, Resting heart rate, BMI, Pulse wave velocity, Blood catecholamines: Epinephrine, Blood catecholamines: Norepinephrine, Muscular strength measurements","Age, Continuous, Sex: Female, Menopausal Status, Blood Pressure, Resting Heart Rate, Pulse Wave Velocity, Blood Epinephrine Levels, Blood Norepinephrine Levels, Muscular Strength, BMI","Age, Continuous, Sex: Female, Race (NIH/OMB), Menopausal status, Blood pressure, Resting heart rate, Pulse wave velocity, Blood catecholamine levels (Epinephrine, Norepinephrine), Muscular strength"
NCT03497429,"Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Region of Enrollment, Height, Weight, Body Mass Index (BMI), Eastern Cooperative Oncology Group (ECOG) Performance Status, Diagnosis, Prior Surgery/Procedure, Prior Radiation Therapy, Breast Cancer Susceptibility Gene 1 (BRCA1) Mutant, Breast Cancer Susceptibility Gene 2 (BRCA2) Mutant, ","Age, sex, ECOG Performance Status, tumor type, prior therapy details, hematology parameters (absolute neutrophil count, platelet count, hemoglobin), kidney function tests (serum creatinine, creatinine clearance), liver function tests (total bilirubin, AST, ALT), coagulation parameters (prothrombin time, activated partial thromboplastin time), reproductive status, contraception method, presence of CNS metastases, presence of ascites or pleural effusion, history of hypersensitivity to study drugs or their analogs, history of serious uncontrolled diseases or infections, history of gastrointestinal diseases or surgeries that could interfere with drug absorption, substance use history, pregnancy or breastfeeding status, HIV status, hepatitis B and C status","Age, Sex: Female, Male, Performance Status (ECOG), Race/Ethnicity, Customized, Region of Enrollment, Height, Weight, Body Mass Index (BMI), Hemoglobin Level, Platelet Count, Absolute Neutrophil Count, Serum Creatinine or Creatinine Clearance, Total Bilirubin, AST (Aspartate Aminotransferase), ALT (Alanine Aminotransferase), Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT)","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Weight (kg), Height (cm), Body Surface Area (BSA), Hemoglobin (g/dL), Absolute Neutrophil Count (per ŒºL), Platelet Count (/ŒºL), Serum Creatinine or Creatinine Clearance (mL/min), Total Bilirubin (mg/dL), AST (U/L), ALT (U/L), Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT), Taking bisphosphonates (yes/no), Presence of CNS metastases (yes/no), Use of Steroids (yes/no, if yes, dose and frequency)","Age, Continuous, Sex: Female, Male, Performance Status (ECOG), Tumor Type, Prior Therapy, Baseline Laboratory Values (Hematology, Kidney Function, Liver Function, Coagulation), Contraception Method, Disease Status, Presence of CNS Metastases, Baseline Symptomatology, Weight, Height, Body Surface Area (BSA)"
NCT03922945,"Age, Continuous, Age, Customized, Sex: Female, Male, Ethnicity (NIH/OMB), Race/Ethnicity, Customized, Region of Enrollment, BMI Categories, ","Age, gender, baseline BMI, weight, height, waist circumference, blood pressure, heart rate, history of obesity-related comorbidities, physical activity level, dietary habits, medication use, smoking status, alcohol consumption, family history of obesity or related metabolic conditions, puberty status, laboratory values (including lipid profile, fasting glucose, HbA1c, liver function tests, thyroid function tests), and mental health status (including history of depression or other psychiatric conditions).","Age, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Weight, Height, Body Mass Index (BMI), Waist Circumference, Blood Pressure, Heart Rate, Pubertal Stage, Physical Activity Level, Dietary Intake, Medication Use, Contraceptive Use (for females), Depression Scale Score, Quality of Life, Sleep Patterns, Academic Performance, Parental BMI","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Weight, Height, Body Mass Index (BMI), Waist Circumference, Blood Pressure, Heart Rate, Temperature, Physical Activity Level, Dietary Habits, Medication Use, Obesity-Related Comorbidities, Depression Scale Score, Quality of Life, Sleep Patterns, Family History of Obesity, Family History of Cardiovascular Diseases, Smoking Status, Alcohol Consumption, Contraceptive Use (for females), Tanner Stage","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Body Mass Index (BMI), Weight, Height, Waist Circumference, Hip Circumference, Waist-to-Hip Ratio, Blood Pressure, Heart Rate, Physical Activity Level, Dietary Habits, Medication Use, Contraceptive Use (for females), Smoking Status, Alcohol Consumption, Sleep Patterns, Quality of Life, Depression Scale, Anxiety Scale, Self-Esteem Scale, Eating Behavior Questionnaire, Family History of Obesity, Family History of Cardiovascular Diseases"
NCT01175902,"Age, Continuous, Sex: Female, Male, Region of Enrollment, Spherical equivalent, Central corneal thickness, Mean deviation of visual field, ","age, sex, best-corrected visual acuity, optic nerve head cupping, visual field loss, untreated IOP measurements, central corneal thickness, open-angle confirmation by gonioscopy, baseline diurnal IOP, baseline diurnal OPP, baseline systolic blood pressure, baseline diastolic blood pressure","Age, Sex: Female, Male, Best-corrected visual acuity, Intraocular Pressure (IOP), Central Corneal Thickness, Vertical Cup-to-Disc Ratio, Visual Field Loss, Blood Pressure (BP), Heart Rate (HR), Ethnicity (NIH/OMB), Race (NIH/OMB)","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race/Ethnicity, Customized, Best-corrected visual acuity, Intraocular pressure (IOP), Central corneal thickness, Visual field defect status, Optic nerve head cupping, Vertical cup-to-disc ratio, Open-angle status confirmed by gonioscopy","Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race (NIH/OMB), Best-corrected visual acuity, Intraocular pressure (IOP), Central corneal thickness, Visual field defect status, Optic nerve head cupping, Vertical cup-to-disc ratio, Open-angle status confirmed by gonioscopy"
NCT03380000,"Age, Categorical, Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Region of Enrollment, Mean arterial pressure, ","Age, race/ethnicity, body mass index (BMI), resting systolic blood pressure, resting diastolic blood pressure, total cholesterol, LDL cholesterol, fasting blood triglycerides, fasting blood glucose, HbA1c, menopausal status duration, physical activity level, dietary nitrate intake, alcohol consumption, history of cardiovascular diseases, medication use (excluding exclusion criteria medications)","Age, Continuous, Sex: Female, Menopausal status, Duration since menopause, Body Mass Index, Resting systolic blood pressure, Resting diastolic blood pressure, Pulse pressure, Mean arterial pressure, Heart rate, Total cholesterol, Low-density lipoprotein (LDL), High-density lipoprotein (HDL), Triglycerides, Fasting blood glucose, Glycated hemoglobin (HbA1c), Serum nitrate and nitrite levels, Dietary nitrate intake, Physical activity level, Alcohol consumption, Caffeine consumption","Age, Continuous, Sex: Female, Menopausal status, Body Mass Index, Resting systolic blood pressure, Resting diastolic blood pressure, Pulse pressure, Mean arterial pressure, Heart rate, Total cholesterol, LDL cholesterol, HDL cholesterol, Triglycerides, Fasting blood glucose, Hemoglobin A1C, Physical activity level, Dietary nitrate intake, Alcohol consumption, Caffeine consumption","Age, Continuous, Sex: Female, Menopausal Status, Body Mass Index, Resting Systolic Blood Pressure, Resting Diastolic Blood Pressure, Pulse Wave Velocity, Arterial Stiffness, Total Cholesterol, Low-density Lipoprotein (LDL) Cholesterol, High-density Lipoprotein (HDL) Cholesterol, Triglycerides, Fasting Blood Glucose, Hemoglobin A1C, Physical Activity Level, Dietary Nitrate Intake,"
NCT00279201,"Age Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Weight, Body Mass Index (BMI), Duration of Diabetes, Glycosylated Hemoglobin (HbA1c), 1,5 Anhydroglucitol (1,5 AG), Mean of Pre-Meals Blood Glucose, Mean of Post Meals Blood Glucose (Postprandial), Average of All Blood Glucose, Fasting Blood Glucose, ","Age, sex, duration of type 2 diabetes, current oral antidiabetes medications, baseline HbA1c, fasting plasma glucose, postprandial plasma glucose, body mass index (BMI), history of hypoglycemia, renal function tests, liver function tests, lipid profile, blood pressure, heart rate, history of cardiovascular disease","Age, Sex: Female, Male, Body Mass Index (BMI), Duration of Diabetes, Baseline HbA1c, Fasting Plasma Glucose, Oral Antidiabetic Medication Use, Insulin Use History, Hypoglycemic Episodes, Blood Pressure, Lipid Profile (Total Cholesterol, LDL, HDL, Triglycerides), Renal Function Tests (eGFR, Serum Creatinine), Liver Function Tests (AST, ALT, Total Bilirubin), Cardiovascular Disease History","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Diabetes, Body Mass Index (BMI), Baseline HbA1c, Oral Antidiabetic Medications at Baseline, Blood Pressure, Lipid Profile at Baseline, Kidney Function Tests","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index (BMI), Duration of Diabetes, Baseline HbA1c, Oral Antidiabetic Drug (OAD) Use, Hypoglycemic Events History, Blood Pressure, Lipid Profile, Kidney Function Tests"
NCT03708770,"Age, Customized, Sex: Female, Male, Ethnicity (NIH/OMB), Region of Enrollment, Fistula Type, Access Arm, Access Artery, Access Vein, ","Age, sex, race/ethnicity, duration of chronic kidney disease, baseline kidney function (e.g., eGFR), type of hemodialysis (e.g., in-center, home), frequency of hemodialysis sessions per week, previous vascular access history, target vein diameter, target artery diameter, presence of central venous stenosis or occlusion, NYHA heart failure class, history of cardiovascular disease, history of diabetes mellitus, blood pressure, body mass index (BMI), hemoglobin level, platelet count, coagulation profile (e.g., INR, aPTT), serum albumin, serum creatinine, electrolytes (e.g., potassium, calcium, phosphorus), C-reactive protein (CRP), medications (e.g., antihypertensives, anticoagulants, immunosuppressives), smoking status","Age, Sex: Female, Male, Race/Ethnicity, Chronic Kidney Disease Stage, Dialysis Status, Target Vein Diameter, Target Artery Diameter, Previous AVF Attempts, NYHA Heart Failure Class, History of Vascular Access, Hemoglobin Level, Platelet Count, Serum Creatinine Level","Age, Continuous, Sex: Female, Male, Chronic Kidney Disease Stage, Dialysis Status, Target Vein Diameter, Target Artery Diameter, Body Mass Index (BMI), Hypertension Status, Diabetes Status","Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Chronic Kidney Disease Stage, Dialysis Status, Vascular Access History, Target Vein Diameter, Target Artery Diameter"
NCT00447382,"Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Height, Body weight, BMI (Body Mass Index), HbA1c (Glycosylated haemoglobin), Diabetes History, ","Age, sex, duration of diabetes, BMI, HbA1c, fasting plasma glucose, total daily insulin dose, insulin regimen (basal-bolus), history of hypoglycemia, history of diabetic ketoacidosis, blood pressure, lipid profile (total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides), renal function tests (serum creatinine, eGFR), liver function tests (AST, ALT, bilirubin), thyroid function tests (TSH, free T4), presence of diabetes-related complications (retinopathy, nephropathy, neuropathy, cardiovascular disease)","Age, Sex: Female, Male, Body mass index, Duration of diabetes, Basal insulin dose, Bolus insulin dose, Total daily insulin dose, HbA1c, Fasting plasma glucose, Postprandial plasma glucose, Insulin antibodies, Blood pressure, Heart rate, Kidney function tests, Liver function tests","Age, Continuous, Sex: Female, Male, Body mass index, Duration of Type 1 Diabetes, Baseline HbA1c, Total Daily Insulin Dose, Insulin Regimen (Basal, Bolus), Fasting Plasma Glucose, Blood Pressure, Kidney Function Tests (e.g., Serum Creatinine), Liver Function Tests (e.g., AST, ALT), Lipid Profile (Total Cholesterol, HDL, LDL, Triglycerides), Presence of Diabetes-related Complications (e.g., Retinopathy, Neuropathy, Nephropathy)","Age, Continuous, Sex: Female, Male, Duration of Diabetes, Body Mass Index, HbA1c, Fasting Plasma Glucose, Total Daily Insulin Dose, Basal Insulin Dose, Bolus Insulin Dose, Number of Daily Insulin Injections, Hypoglycemic Episodes, Blood Pressure, Heart Rate"
